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Abstract 25 
Nucleosomes are essential for proper chromatin organization and the maintenance of genome integrity. 26 
Histones are post-translationally modified and often evicted at sites of DNA breaks, facilitating 27 
recruitment of repair factors. Whether such chromatin changes are localized or genome-wide is debated. 28 
Here we show that cellular levels of histones drop 20-40% in response to DNA damage. This histone-29 
loss occurs from chromatin, is proteasome mediated and requires both the DNA damage checkpoint and 30 
INO80 nucleosome remodeler.  Histone level reduction was confirmed by SILAC-based mass 31 
spectroscopy, genome-wide nucleosome mapping and fluorescence microscopy. Chromatin 32 
decompaction and increased fiber flexibility accompany histone degradation, both in response to DNA 33 
damage and upon artificially reducing histone levels. As a result, recombination rates and DNA repair 34 
focus turnover are enhanced. Thus, we propose that a generalized reduction in nucleosome occupancy 35 
is an integral part of the DNA damage response, providing mechanisms for enhanced chromatin mobility 36 
and homology search.  37 
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Introduction 50 
The genomic DNA of eukaryotes is highly organized and packed into chromatin. The most basic unit of 51 
chromatin is the nucleosome which is formed by 146 base base pairs of DNA that wrap around an 52 
octameric core of histone proteins. Chromatin remodelers use the energy from ATP hydrolysis to change 53 
the local state of chromatin by sliding/spacing or ejecting nucleosomes. These actions regulate gene 54 
transcription1, replication2, chromatin structure and DNA repair genome-wide3,4. Cellular genomes are 55 
constantly exposed to different sources of DNA damage, requiring that the repair machinery both 56 
disrupts and restores chromatin structure5. Heterochromatic chromatin tends to obstruct repair protein 57 
access and DNA double-strand breaks (DSB) found in heterochromatin relocate to the edge of such 58 
domains6-8, a phenomenon that requires a certain degree of physical mobility.  59 
In budding yeast and human cells exposed to DNA damage, increases in chromatin mobility 60 
were observed both at lesions9-11 and at undamaged sites where no DSB could be detected10,12. The 61 
chromatin remodeler INO80-C and activation of the DNA damage checkpoint (DDC) were implicated 62 
in both processes9,10,12. Functionally, enhanced local DSB mobility correlated with efficient repair by 63 
homologous recombination (HR)9. Modelling algorithms (Amitai A., Seeber A. et al., in preparation) 64 
suggest that mobility could enhance the search for the donor sequence required for homology-based 65 
repair. Consistently, elevated chromatin mobility was shown to result in genomic translocations in 66 
human cells11. However, the mechanisms that underlie enhanced chromatin mobility have remained 67 
elusive. Here we show that nucleosome degradation triggered by remodelers and checkpoint proteins 68 
enhances chromatin movement and accessibility, and promotes efficient repair. 69 
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Results 76 
DNA damage triggers extensive histone loss from chromatin 77 
To investigate whether DNA damage and DDC activation affect chromatin structure and/or composition 78 
genome-wide, we used quantitative SILAC mass spectrometry in Saccharomyces cerevisiae and 79 
measured histone abundance before and after acute treatment (1 hour) with the radiomimetic drug 80 
Zeocin. Relative ratios of non-modified histone peptides (damage over control - L/H) indicate a 81 
substantial loss of 20±6 % of all core histones H2A, H2B, H3 and H4 (Fig. 1a, Supplementary Fig. 82 
1a-f). Interestingly, levels of the histone variant Htz1 (H2A.Z) remained rather stable. Quantitative 83 
immunoblot analysis confirmed our observations and showed robust DDC activation (γH2A signal, 84 
Rad53 upshift) along with a dose-dependent relationship between histone H3/H4 loss and Zeocin 85 
treatment (Fig. 1b). The same effect was observed using another source of DNA damage, ionizing 86 
radiation (γ-IR) (Supplementary Fig. 2a-d). 87 
Despite being highly quantitative for protein abundance, mass spectrometry data does not 88 
distinguish between histone pools and nucleosomes, and it lacks positional information. To investigate 89 
whether entire nucleosomes were lost globally following DNA damage or at specific genomic loci, we 90 
performed genome-wide nucleosome mapping. First, we found that the positioning of nucleosomes 91 
around the promoters of yeast genes changed little following damage induction (Fig. 1c). To assess 92 
global changes in nucleosome abundance, we implemented internal standardization by mixing defined 93 
numbers of Candida glabrata cells with the experimental Saccharomyces cerevisiae cells prior to 94 
chromatin preparations13. Normalization of the S. cerevisiae reads with respect to the C. glabrata reads 95 
showed that there was a drop in nucleosome occupancy both within promoters and across coding regions 96 
following Zeocin treatment (Fig. 1c and Supplementary Table 1). This effect was just as strong on a 97 
subset of 750 low expression genes (Fig. 1c) as on highly transcribed genes (Supplementary Fig. 2e), 98 
suggesting that transcription is unlikely to regulate or drive the reduction. Finally, we found no 99 
preferential depletion specific structural elements such as centromeres or telomeres, arguing that the 100 
effect is widespread. 101 
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To determine the kinetics of histone reduction, we used time-lapse live cell tracking of 102 
functional fluorescently labeled ectopic histone H2B (H2B-CFP) or control Htz1-mEos and Nup49-103 
GFP, which labels the nuclear rim (Fig. 1d, Supplementary Fig. 2g, Supplementary Video 1). We 104 
used microfluidic chambers to trap cells and pulse-treated them for 1h with Zeocin, generating roughly 105 
4-7 DSBs per genome14. Histone H2B degradation (20±1.7% compared to undamaged cells) occurred 106 
within 30 minutes of Zeocin exposure. Neither Nup49-GFP (Supplementary Fig. 2f) nor the Htz1-107 
mEos control showed differential loss following DNA damage, suggesting that the induced histone 108 
degradation only targets core histones (Fig. 1d). Combined with our mass-spectroscopy and immunoblot 109 
data, these results suggested a rapid degradation of histones, rather than simply eviction from chromatin. 110 
Earlier, Gunjan et al. had shown that an excess of nonchromatin-bound histones is phosphorylated by 111 
the Rad53 checkpoint kinase, and then subsequently ubiquitinated and subject to proteasomal 112 
degradation15,16. This prompted us to test whether the proteasome inhibitor MG132 or mutation of the 113 
26S proteasome (pre1-1, pre2-2)17 would suppress the loss of histones from chromatin. Consistent with 114 
proteasome involvement, both the inhibitor and the mutations in PRE1 and PRE2 genes suppressed the 115 
DNA damage-induced H3 or H4 degradation (Fig. 2). Moreover, by synchronizing cells in G1, or 116 
releasing them into S phase prior to damage, we found that degradation occurs in both phases of the cell 117 
cycle (Supplementary Fig. 3). 118 
We considered that the observed histone loss might be accentuated by impaired expression of 119 
histone genes, which are tightly regulated and show promoter-dependent upregulation in S phase. To 120 
eliminate this confounding factor, we placed the H3 and H4 genes under the control of the galactose 121 
promoter in a strain in which both endogenous H3 and H4 copies were deleted (histone-shutdown strain, 122 
Supplementary Fig. 4a). With constitutive H3/H4 expression (growth in media with low level 123 
galactose), we found the same depletion effect following exposure to Zeocin as in cells with endogenous 124 
histone genes, arguing that DNA damage induces an active degradation of histones, and not simply a 125 
loss of new histone synthesis (Supplementary Fig. 4). The loss of histones is rapid and so substantial 126 
that by 1h, every third nucleosome could be removed from DNA. It is therefore likely that higher-order 127 
chromatin structure changes in response to DNA damage. 128 
 129 
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Damaged chromatin increases mobility, decompaction and flexibility 130 
The increase in chromatin movement following DNA damage has been well documented, although the 131 
mechanisms leading to enhanced mobility remained elusive12,18,19. To see if histone loss might be at the 132 
root of this phenomenon, we examined the physical characteristics of yeast chromatin under the same 133 
conditions that triggered histone loss. Using improved imaging protocols, we monitored the volume of 134 
chromatin domains in three-dimensional (3D) space, the inherent flexibility of the nucleosome polymer 135 
and the physical movement of fluorescently tagged sites. 136 
Previous studies in which chromatin mobility was quantified used low sampling rates during 137 
live cell imaging (∆t=1.5 sec) to determine the trajectory of a moving locus and the area explored (radius 138 
of constraint)9-12,20. However, such low time-resolved data yields little information on chromatin fiber 139 
compaction or flexibility. To resolve this, we used a novel high-speed imaging technique (300 ms or 80 140 
ms imaging intervals) with which we first confirmed that increased chromatin mobility can be monitored 141 
at a non-damaged site (MET10) in cells responding to widespread DNA damage (Fig. 3a, 142 
Supplementary Fig. 5a). By applying an analysis based on polymer models to our high-speed imaging 143 
data (Amitai A., Seeber A. et al., in preparation), we estimated biophysical parameters that predict both 144 
the expansion of chromatin (reflected by an increase in the anomalous exponent α) and the loss of 145 
constraining forces that limit chromatin movement (as seen by decrease in the spring constant KC) (Fig. 146 
3b and Supplementary Fig. 5b). 147 
To examine whether the 3D volume of a defined chromatin domain was altered within the 148 
nucleus, we used super-resolution microscopy coupled with subsequent machine-learning and 3D pixel 149 
classification analysis. Using this technique, we measured the change in volume of TetR-mCherry 150 
tagged chromosomal loci (chromatin expansion) in cells fixed 30 min after exposure to different 151 
amounts of Zeocin (Fig. 3c). Indeed, we scored a dose-dependent decompaction of S phase chromatin: 152 
3D TetR-mCherry foci volumes expanded with increased amounts of damage (Fig. 3d). 153 
The second prediction from the polymer modeling of locus dynamics was that the flexibility of 154 
the chromatin fiber would be enhanced after DNA damage. Thus, we monitored chromatin flexibility 155 
with confocal microscopy and measured the 3D distances between two differentially labeled genomic 156 
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loci positioned on the same chromosome arm. We used two independent sets of loci spaced at genomic 157 
distances of either 320 kbp on Chr XIV or 50 kbp on Chr III. For the first set, we synchronized cells, 158 
fixed them before or after Zeocin treatment and calculated the average of all distances measured between 159 
the lacI-GFP and TetR-mRFP fluorescently tagged loci (Fig. 4a). We find that after DNA damage, the 160 
average inter-spot distance increases significantly both in G1- (0.97-1.2 µm) and S-phase cells (0.99-161 
1.12µm). For the second set of data, a similar approach was taken but we measured the inter-distance 162 
between CFP-lacI and TetR-mRFP tagged foci on Chr III in real time (Supplementary Video 2). In all 163 
cases we included Rad52-GFP and ensured that there was no overlap of Rad52-GFP with either of the 164 
other two fluorescent signals, assuring that the measured changes do not arise from effects linked to 165 
local DNA repair events. Analysis of relative mean squared distance changes and the average of all 166 
measured inter-distances reveals a robust increase in inter-spot dynamics and distances following Zeocin 167 
treatment (Fig. 4b). These data are consistent with a model in which damage-triggered histone 168 
degradation reduces the amount of nucleosomal constraints within the chromatin fiber, causing 169 
chromatin to expand. The enhanced physical dynamics would be a reflection of increased flexibility. 170 
Histone abundance dictates chromatin movement and decompaction 171 
To confirm that increased chromatin mobility and decompaction arise as a consequence of histone loss, 172 
we made use of a histone-shutdown strain that expresses H3 and H4 under the control of the GAL1-10 173 
promoter which is susceptible to media-controlled repression as well as induction (Fig. 5a). After 1h in 174 
galactose, we released α-factor arrested cells bearing this shutdown construct into raffinose-containing 175 
medium. Depending on the concentration of raffinose, we observed reduced GAL1-10-driven 176 
expression, lowering histone levels in a controlled manner by 39% within an hour (Supplementary Fig. 177 
6ab). This artificial reduction of histones did not cause DNA damage checkpoint activation, even when 178 
levels were reduced extensively (Supplementary Fig. 6b). Using the appropriate galactose:raffinose 179 
mixture, however, we could reduce histone levels in a controlled manner, even in the absence of damage 180 
(Fig. 5b), after which we monitored both chromatin decompaction (Fig. 5c) and a striking increase of 181 
chromatin mobility, measured at the MGS1 locus after 1h on the defined medium (Fig. 5d).  182 
To further validate these findings, we made use of a mutant bearing deletions of both high-183 
mobility group protein one (HMGB1) orthologues NHP6A and NHP6B (nhp6a∆nhp6b∆, for simplicity 184 
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called nhp6∆), which was previously described as having reduced levels of core histone proteins21. Here, 185 
we show that nhp6∆ does not trigger endogenous damage checkpoints, and has neither an altered FACS 186 
distribution (Fig. 6b) nor Rad53 activation (Supplementary Fig. 7a), yet by tracking chromatin 187 
mobility with the high-speed imaging regime we find that the mobility of two labeled foci, MET10 and 188 
PES4, is significantly enhanced in nhp6∆ cells (Fig. 6cd, Supplementary Fig. 7b). High resolution 189 
time-lapse imaging of the GFP-LacI-tagged PES4 or the TetR-mCherry-tagged MET10 locus further 190 
confirms an increase in chromatin flexibility which is reflected by a decrease in the spring constant KC, 191 
and a positive trend in the anomalous exponent α (Fig. 6e, Supplementary Fig. 7cd). Finally, using 192 
super-resolution microscopy we monitored an increase in 3D volume of the TetR-mCherry labeled 193 
MET10 locus in nhp6∆ cells, which was more pronounced in an asynchronous culture, for unknown 194 
reasons (Fig. 6f). Combined with the effects observed in the histone shutdown strain, these 195 
manipulations argue for a direct link between histone levels and chromatin movement. 196 
Histone loss is checkpoint and INO80-C dependent and modulates recombination efficiency  197 
DNA damage activates the central DDC kinase Mec1 (ATR) which initiates a widespread 198 
phosphorylation cascade leading to a global damage response and cell-cycle arrest. Additionally, repair 199 
proteins such as Mre11, Exo1, Rad51 and Rad52 act locally on DNA to mediate resection and 200 
preparation for either repair by homologous recombination or end-joining. Among Mec1 targets are the 201 
downstream effector kinase Rad53 (CHK2)22 and multiple subunits of the INO80-C remodeler23,24. Since 202 
both INO80-C and DDC proteins were implicated in a general increase in chromatin mobility in 203 
response to DNA damage12, we hypothesized that these factors may also regulate histone loss, which 204 
we find can trigger enhanced chromatin mobility. 205 
Using immunoblotting, we found that strains lacking checkpoint kinases Mec1 or Rad53 206 
completely abolished histone degradation after Zeocin treatment (Fig. 7ab). More strikingly, the same 207 
dependency was observed for strains deleted for INO80-C subunits Arp8, Ies4 or Arp5 which do not 208 
participate in the DDC, but remodel nucleosomes (Fig. 7ab). Importantly, histone loss occurred 209 
independently of Rad51 and Exo1 showing that local repair events are not necessary for the DDC-210 
triggered degradation of histones. We further confirmed this with two other assays: H2B-CFP 211 
fluorescence monitoring over time (Fig. 7c) and super-resolution microscopy of tagged locus 3D 212 
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volumes (Fig. 7d). In all cases we find that histone loss and chromatin expansion required the Mec1-213 
mediated checkpoint and intact INO80-C: no histone loss or chromatin expansion is seen in mec1∆sml1∆ 214 
and rad53∆ nor in arp8∆), while cells bearing sml1∆ (a control for the mec1∆sml1∆) and rad51∆ 215 
behaved like their wild-type counterparts in response to damage (Fig. 7c-d). 216 
The main role of the DDC kinase Mec1/ATR is to trigger a cell-wide stress response that helps 217 
the cell cope with DNA damage. This appears to be, at least in part, mediated by the remodeler INO80-218 
C23,24. The importance of chromatin-remodeling in histone degradation, is not entirely surprising, given 219 
that Ino80 was recently shown to interact with Cdc48, an AAA+ ATPase involved in proteasome-220 
dependent protein degradation25. Moreover, both Mec1 and INO80-C are linked to RNA Pol II eviction 221 
at sites of replication fork-transcription collision24. Thus, these genetic dependencies further validate our 222 
model that histone degradation and chromatin expansion are the key phenomena underlying damage-223 
enhanced chromatin movement (Fig. 7e). Our data further suggest that a failure to degrade histones 224 
might impair the access of repair proteins to chromatin, giving an explanation for previously observed 225 
repair deficiencies in these mutants26,27.  226 
To examine the functional relevance of the observed reduction in nucleosome occupancy 227 
triggered by DNA damage, and to test the hypothesis that nucleosome reduction facilitates homologous 228 
recombination and thus DNA repair, we made use of a recombination assay that monitors the integration 229 
rates of two different URA3 cassettes (800 bp homology or 82 bp homology) at two independent loci 230 
(MGS1 and URA3). In otherwise isogenic haploid strains, we impaired INO80-C activity by disrupting 231 
its nucleosome-binding subunit Arp8 (arp8∆) or deleted both NHP6 genes, to reduce nucleosome levels 232 
genome-wide21. Consistent with previously reported recombination defects in arp8∆26,27, we see reduced 233 
recombination rates in this mutant, while rates were significantly increased in the nhp6∆ strain (Fig. 234 
8a). Interestingly, Liang et al. had shown that deletion of the histone H3-H4 gene copy 2 (HHT2-HHF2) 235 
can confer resistance to DNA damaging agents and restore the viability of DDC mutants under stress 236 
conditions16. Thus, we hypothesized that artificially lowering histone levels by Nhp6 removal might 237 
rescue arp8∆ sensitivity and even increase the fitness of wild-type cells under damaging conditions. 238 
Using a recovery assay that scores cell survival after a 1h treatment with increasing amounts of Zeocin, 239 
we found that nhp6∆ cells recover better from acute DNA damage than a wild-type strain, and that 240 
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lowering nucleosome occupancy by deleting NHP6 partially rescues the Zeocin sensitivity of an arp8∆ 241 
strain (Fig. 8b). 242 
The observation that increased recombination rates in nhp6∆ cells stem from changes in 243 
nucleosome occupancy, prompted us to test whether gene targeting rates could also be increased by 244 
other approaches that reduce histone levels. Hence, we used the same recombination assay in our 245 
histone-shutdown strain and followed the integration of two different hygromycin-resistance markers 246 
either at ATG2 or MGS1. This was done directly after a 2h incubation in raffinose-containing medium 247 
(raffinose only or a defined 1:20 galactose:raffinose mixture) which reduces histone H3 and H4 levels 248 
(Fig. 8c). Consistent with the nhp6Δ experiment, we found that a reduction of histone levels by means 249 
of transcriptional repression significantly enhances the integration rates of both ATG2::hygro and 250 
MGS1::hygro PCR products (Fig. 8d). 251 
Finally, we used fluorescence microscopy to follow the kinetics of Rad52-GFP focus formation 252 
and dissolution during 16h after a brief exposure to Zeocin. We find fewer Rad52 (BRCA2) foci in 253 
nhp6∆ vs wild-type cells (Supplementary Fig. 7e). Since Rad52 accumulates at sites of damage and 254 
disappears upon completion of recombination mediated repair28, this result suggests that a reduction in 255 
histone levels enhances the turnover of the recombination-mediated repair reaction. 256 
Discussion 257 
In a robust combinatorial approach, we used quantitative mass spectrometry, fluorescent live cell 258 
microscopy and genome-wide nucleosome mapping to show that core histone proteins but not histone 259 
variant Htz1 are degraded from chromatin when the genome is challenged with DNA damage. This 260 
requires checkpoint activation, INO80-C function and is mediated through the proteasome. Furthermore, 261 
reducing the levels of histones on DNA enhances chromatin mobility, decompaction and fiber 262 
flexibility. Proteins that function uniquely in recombination-mediated DNA repair (Rad51, Exo1) were 263 
not involved in histone loss, while the Mec1-target INO80-C, a chromatin remodeler implicated in 264 
efficient repair, is. Other studies have postulated a release of chromosomal tethers around the centromere 265 
as the source for altered chromatin mobility20,29. This, however, is unable to account for the observed 266 
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expansion of non-centromeric chromatin nor for the observed dependence on INO80-C for these events. 267 
Furthermore, there is no evidence to date that centromeres delocalize in response to damage. 268 
While we cannot rule out that other mechanisms also contribute to nuclear or chromosomal 269 
motion, our data irrefutably demonstrate that a reduction of histone levels, even in the absence of DNA 270 
damage, is sufficient to decompact chromatin and enhance chromatin mobility. We suggest that histone 271 
degradation facilitates the search for donor sequences, an event required for DSB repair by homologous 272 
recombination with a non-sister template, and that chromatin decompaction might further enhance the 273 
access of DNA (both damage and template) to the repair machinery. On the other hand, mobility might 274 
also help disrupt improper pairing events during HR. Recombination assays indicate that a reduction in 275 
nucleosome occupancy by NHP6 deletion cells or by means of transcriptional histone gene repression 276 
increases gene targeting rates and enhances the turnover rate of repair processes. While controlled 277 
histone loss might facilitate repair, its misregulation and the resulting effects in chromatin structure and 278 
dynamics are likely to promote oncogenic translocations that might drive tumorigenesis.  279 
Taken together, our study identifies histone loss as a fairly immediate response to DNA damage 280 
checkpoint activation and implicates remodeler-dependent histone degradation as a novel and integral 281 
part of the DNA damage response. We demonstrate how changes in chromatin composition can affect 282 
the physical characteristics of chromatin and we show that artificial histone level reduction can be used 283 
to increase recombination efficiency. To understand how the posttranslational modification status of 284 
histones and the entire chromatin proteome changes upon DNA damage requires further investigation. 285 
We speculate that gene targeting rates in mammalian cells can also be improved by manipulating histone 286 
occupancy. 287 
 288 
 289 
 290 
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Figure legends 396 
Figure 1: DNA damage triggers a global loss of core histones from chromatin 397 
Damage-dependent global histone degradation quantified by (a) SILAC mass spectrometry on 398 
chromatin fractions from two independent cells pools (for further information see Supplementary Fig. 399 
1). Boxplots show light/heavy histone peptide distribution indicating the degradation of core histones 400 
and, to a lesser extent, Htz1 (H2A.Z). (b) Right: Representative immunoblot analysis using antibodies 401 
against H3 and H4 on whole cell extracts from asynchronous (asy.) wild-type cultures in response to 402 
Zeocin treatment. Rad53 and γH2A were probed to confirm checkpoint activation. MCM2 was used to 403 
control for loading and Ctr. represents bands on the Ponceau stained membrane. Left: Schematic 404 
illustrates the experimental setup and bar graph shows mean values of immunoblot quantification of H3 405 
and H4 blots from at least four independent experiments upon Zeocin treatment relative to the control 406 
condition. Asterisk indicates phosphorylation-dependent Rad53 mobility shift. (c) Genome-wide 407 
nucleosome mapping. Scheme illustrates the effect of histone loss on nucleosome reads. Graphs show 408 
the distribution of nucleosome reads over all genes and over the bottom 10% of low level expressed 409 
genes aligned to the TSS from four independent experiments (±s.d. is shaded). (d) Live single-cell 410 
microscopy of H2B-CFP and Htz1-mEos. Graphs show the experimental outline, representative images 411 
and the mean fluorescent signals of all individual cells (cell numbers indicated in graph) per treatment 412 
over time relative to the control (Ctr.) condition. Scale bar is 2 µm. Uncropped blot images are shown 413 
in Supplementary Dataset 1. Boxplots in a represent median values, interquartile ranges and whiskers. 414 
Graphs in b,d show means ± s.e.m, in c ± s.d.. 415 
 416 
Figure 2: Histones are degraded by the proteasome 417 
(a) Scheme illustrates the experimental setup. (a-b) Immunoblot analysis and quantification showing 418 
H3 or H4 levels before and after Zeocin treatment in whole cell extracts from asynchronously (Asy.) 419 
growing wild-type cells (a, experiment was done in triplicate) or erg6∆ cells (b, experiment was done 420 
in triplicate) treated with the proteasome inhibitor MG132. MG132 permeability is increased in erg6∆ 421 
cells which rescues histone H3 from being degraded. Antibodies against ubiquitin (Ubi) indicate proper 422 
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function of the MG132 inhibitor validating the experimental protocol.  (c) Immunoblot analysis and 423 
quantification showing H4 levels in response to Zeocin treatment in wild-type and 26S proteasome 424 
dysfunctional cells (pre1-1, pre2-2) (experiment was done in four replicates). Mutations in PRE1 and 425 
PRE2 suppress histone H4 degradation. Rad53 and γH2A were probed to confirm checkpoint activation. 426 
Ctr. shows loading and represents bands on the original gel (UV-TGX stained). Uncropped blot images 427 
are shown in Supplementary Dataset 1. Bar graphs show means ± s.e.m.. Asterisk indicates 428 
Phosphorylation-dependent Rad53 mobility shift. 429 
 430 
Figure 3: High-speed, live cell imaging and super-resolution microscopy shows chromatin 431 
expansion and enhanced flexibility following DNA damage 432 
(a) Diagram with representative image shows the experimental setup for high-speed imaging. Graph 433 
shows MSD analysis (Δt=300 ms) of the MET10 locus in response to Zeocin treatment indicating a 434 
dose-dependent increases in global chromatin mobility in response to DNA damage (nCtr.=23, nZeo200=15, 435 
nZeo500=21 different cells from three independent experiments). Scale bar is 2 µm. (b) Graphs show the 436 
medians and whiskers of biophysical parameters derived from imaging data and predict chromatin 437 
expansion and flexibility increases after Zeocin treatment. (c) Experimental outline and FACS analysis 438 
of cell cycle stages. (d) Scheme illustrates the 3D super-resolution imaging regime. Boxplots showing 439 
TetR-mCherry focus volume distributions upon Zeocin treatment in S phase cells relative to the control 440 
(Ctr.) condition of multiple single cells (n numbers in graph) from two different cultures. All MSD 441 
graphs represent the mean ± s.e.m. of cells pooled from three independent experiments. Boxplots in d 442 
represent median values, interquartile ranges and whiskers. P-values, *P<0.05, **P<0.01, ***P<0.001, 443 
result from unequal variances t-tests for d or Kolmogorow-Smirnow-Tests for b. Additionally, consult 444 
Supplementary Dataset 2 for mobility parameters and the number of cells analyzed. 445 
 446 
 447 
 448 
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Figure 4: DNA damage increases chromatin flexibility 449 
(a) Upper panel illustrates the experimental setup and procedure for 3D intra-chromosomal distance 450 
measurements between two tagged loci on Chr XIV. Boxplots and cumulative distribution graphs in 451 
lower panel show GFP to mRFP distance distributions from multiple single cells (n numbers in graph) 452 
from two different cultures in fixed condition before and after Zeocin treatment in G1 phase or after 453 
release into S phase. (b) Upper panel illustrates live cell imaging regime used to monitor distance 454 
changes between two loci on the left arm of Chr III over time and upon Zeocin treatment. Exemplary 455 
tracks indicate the movement of CFP and mRFP foci over time. Relative MSD graph in lower panel 456 
shows mean values ± s.e.m from multiple single (nCtr.=13, nZeo=53) cells from two different cultures and 457 
indicates less constrained spot movement upon DNA damage. Boxplots represent median values, 458 
interquartile ranges and whiskers and show the distribution of all measured CFP to mRFP distances. P-459 
values, *P<0.05, ***P<0.001, NS=not significant, result from unequal variances t-tests. 460 
 461 
Figure 5: Artificial histone reduction in the absence of damage triggers chromatin expansion and 462 
increased motion 463 
(a) Schematic showing a method for H3 and H4 level reductions via transcriptional inhibition by 464 
releasing cells into media containing raffinose. A plasmid borne construct in which the GAL1/10 465 
promoter drives the only pair of histone H3/H4 genes is used in the shutdown (SD) strain whereas a 466 
plasmid carrying the wild-type HHT1-HHF1 locus is used in the control strain.  (b) Quantified 467 
Immunoblot data shows histone H4 loss at different time-points after H3/H4 shutdown in raffinose 468 
medium from one experiment (Supplementary Fig. 6). (c) Boxplots and cumulative density graphs 469 
show volume distributions of data derived from 3D-SIM microscopy on multiple single cells (n numbers 470 
in graph) from two different cultures with tagged MGS1 loci upon controlled histone H3/H4 shutdown. 471 
Data is presented relative to the control condition (yellow with black stripes). (d) MSD analysis of the 472 
MGS1 locus in response to controlled histone level reductions. MSD graph in right panel shows 473 
enhanced chromatin movement of the MGS1 locus after controlled histone shutdown via 60 min release 474 
into S phase in raffinose containing medium (nSD(Raff)=30, nControl(Raff)=34, nSD(Gal)=52 different cells from 475 
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three independent experiments). MSD graph in left panel shows that G1 phase chromatin is more mobile 476 
than S phase chromatin but does not further increase mobility upon H3/H4 repression in raffinose 477 
containing medium (nSD(Raff)=30, nControl(Gal)=97 different cells from three independent experiments). All 478 
MSD graphs represent the mean ± s.e.m. of cells pooled from at least three different experiments. 479 
Boxplots in d represent median values, interquartile ranges and whiskers. P-values, ***P<0.001, 480 
NS=not significant, result from unequal variances t-tests. Additionally, consult Supplementary Dataset 481 
2 for mobility parameters and the number of cells analyzed. 482 
 483 
Figure 6: Loss of high-mobility group protein Nhp6 links reduced nucleosome occupancy to 484 
chromatin expansion and enhanced mobility 485 
(a) Cells carrying deletions of both NHP6A and NHP6B (nhp6∆) have less nucleosomes on DNA than 486 
the wild-type cells. (b) Immunoblot quantification from three experiments confirms reduced histone 487 
levels in nhp6∆ cells and FACS analysis show similar cell cycle profiles for wild-type and nhp6∆ cells. 488 
(c-d) MSD graphs derived from high-speed live cell imaging data of nhp6∆ cells (shown in dark green 489 
for the MET10 locus and in light green for the PES4 locus) highlight enhanced chromatin mobility at 490 
two independent genomic loci MET10 and PES4 (nMET10, WT=31, nMET10, nhp6∆=47, nPES4, WT=35, nPES4, 491 
nhp6∆=57 different cells from three independent experiments). (e) Graphs show the medians and whiskers 492 
of biophysical parameters derived from imaging data and predict concurrent loss of constraining forces 493 
on chromatin. Color code as in b. (f) Boxplots of MET10 (TetR-mCherry) foci volumes resulting from 494 
3D-SIM microscopy in multiple asynchronous (asy.) G1 or S phase nhp6∆ and wild-type cells (n 495 
numbers in graph) from two different cultures indicate chromatin expansion in nhp6∆ cells. Color code 496 
as in b. Bar graphs and all MSD data (cells pooled from at least three independent experiments) represent 497 
the mean ± s.e.m.. Boxplots in d represent median values, interquartile ranges and whiskers. P-values, 498 
*P<0.05, **P<0.01, ***P<0.001, result from Kolmogorow-Smirnow-Tests for e or unequal variances 499 
t-tests for f. Additionally, consult Supplementary Dataset 2 for mobility parameters and the number of 500 
cells analyzed. 501 
 502 
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Figure 7: INO80-C and checkpoint proteins regulate histone degradation and chromatin 503 
expansion in response to damage 504 
(a) Representative immunoblot using H3 and H4 specific antibodies on whole cell extracts from wild-505 
type and different mutants in response to DNA damage. Rad53 was probed to confirm checkpoint 506 
activation, tubulin or actin was used as loading control.  (b) Bar graph shows immunoblot quantification 507 
of wild-type, checkpoint mutants and INO80-C mutants from blots derived from nWT=9, nsml1∆=3, 508 
nmec1∆sml1∆=3, nrad53∆sml1∆=3, narp8∆=3, nies4∆=3 different experiments.  (c) Live single-cell microscopy of 509 
H2B-CFP in local repair, checkpoint and INO80-C mutants upon Zeocin treatment. Graphs show the 510 
mean fluorescent signals of all individual cells (cell numbers indicated in graph) per treatment over time 511 
relative to the control (Ctr.) condition. (d) Boxplots show TetR-mCherry focus volume distributions 512 
upon Zeocin treatment in wild-type and different mutant cells (n numbers in graph) from two different 513 
cultures in one experiment released into S phase relative to the control (Ctr.) condition. INO80-C and 514 
Mec1 are required for chromatin expansion. (e) Model suggesting that checkpoint signaling triggers 515 
INO80-C-dependend histone loss leading to subsequent chromatin expansion, enhanced mobility and 516 
chromatin flexibility which finally enhances repair. Uncropped blot images are shown in 517 
Supplementary Dataset 1. Bar graphs b show means ± s.e.m.. Boxplots in d represent median values, 518 
interquartile ranges and whiskers. P-values, *P<0.05, ***P<0.001, NS=not significant, result from 519 
unequal variances t-tests. Asterisk indicates Phosphorylation-dependent Rad53 mobility shift. 520 
 521 
Figure 8: Reduced nucleosome occupancy enhances recombination and rescues arp8∆ sensitivity 522 
(a) Ectopic recombination assay with two different integrative URA3 cassettes in wild-type, arp8∆ and 523 
nhp6∆ strains. The diagram on the left highlights that recombination takes place in the context of 524 
chromatin. Bar graphs show the mean integration frequency ± s.e.m in selected mutants relative to the 525 
wild-type from three independent cultures each. (b) Graph showing the average recovery rate of the 526 
wild-type and different isogenic mutants from an acute treatment with different Zeocin amounts relative 527 
to the control condition (ctr.). Individual points indicate the mean over three independent replicas ± 528 
s.e.m.. (c) Schematic showing the workflow and the strains for H3 and H4 level reductions by means of 529 
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transcriptional inhibition as in Fig. 5a. (d) Ectopic recombination assay with two different hygromycin 530 
(hphMX4) based constructs which target either the ATG2 or MGS1 locus. Bar graphs show the mean 531 
integration frequency ± s.e.m of both constructs in the SD strain relative to the Ctr. strain after 120 min. 532 
pulsed histone H3/H4 reductions in Gal:Raff (galactose:raffinose, 1:20) or raffinose (Raff) medium. 533 
Three independent cultures were tested. P-values, *P<0.05, ***P<0.001, result from two-tailed paired 534 
students t-tests. 535 
 536 
 Online Methods 537 
Yeast growth, cell cycle arrests and flow cytometry 538 
Yeast strains and plasmids used in this study are shown in Supplementary Table 2 and 3. Yeast strains 539 
are all haploid and, except for the SILAC strain and the Htz1-mEos imaging control strain, derived from 540 
the W303 background (Supplementary Table 2). Unless otherwise stated, yeast cultures were grown 541 
at 30 °C until logarithmic (LOG) growth-phase (OD600=0.7; 1x107 cells/ml) prior to Zeocin (Invitrogen) 542 
or γIR exposure at 30°C. Live cell microscopy was done at 25 °C. Flow cytometry samples were 543 
prepared as previously described30. 544 
For controlled GAL1-10::H3/H4 expression experiments coupled with gene targeting assays, 545 
GA-8386 and the relevant control strain cultures (GA-8385) were grown overnight to saturation in YP 546 
galactose/raffinose (YP Gal/Raff 1:5) medium. The next morning, cultures were inoculated in the same 547 
respective medium and grown until logarithmic (LOG) growth-phase (OD600=0.7; 1x107 cells/ml) prior 548 
to pulsed histone level reductions. After reaching LOG phase, cells were washed once and pulsed histone 549 
H3 and H4 level reductions were accomplished via grown in either pre-warmed 30°C YP 550 
galactose/raffinose 1:20 or YP raffinose medium for 120 minutes prior to transformation with the 551 
respective gene targeting selection cassettes. For further information about the gene targeting assay, 552 
please consult “Ectopic recombination assay” section. 553 
For cell cycle arrest and release experiments, 1.5 x 10-8 M alpha factor (Zymo Research) was 554 
added to exponentially growing cultures at a density of OD600=0.5. After 1 hour, another half of the 555 
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initial alpha factor amount was added for 30 minutes and cells were either held in G1 phase or released 556 
into pre-warmed medium for 15-25 minutes prior to Zeocin damage treatment in S phase. Cell fixation 557 
in the relevant experiments was done for 2 minutes at room temperature with 4% Paraformaldehyde. 558 
For all Zeocin or γIR exposure experiments, saturated yeast overnight cultures were diluted to 559 
OD600=0.1 the next morning and grown to LOG phase. In all assays, Zeocin was added directly to G1 560 
arrested, S phase released or asynchronously growing LOG cultures. Cultures were incubated with the 561 
drug for 1 h prior to high-speed tracking microscopy or the indicated amount time periods for other 562 
assays and experiments (Main Figures and Supplementary Figures). For γIR exposure, 5ml of cell 563 
culture was transferred to a 35x10mm petri dish and irradiated in a Faxitron CellRad cell-irradiator until 564 
the indicated dose (Grey) was reached. After γIR treatment, cells were directly harvested for further 565 
downstream Western blot or mass-spectrometry-based analysis. For undamaged conditions, cells were 566 
either imaged immediately for high-speed tracking microscopy or growth was continued along with the 567 
treated samples for the indicated time periods. γIR undamaged control cells were also spread on petri 568 
dishes and harvested after irradiation of treated cells was completed. Further specific growth and 569 
treatment conditions for high-speed tracking live cell microscopy were done according to Seeber et al.12. 570 
The proteasome inhibition assay with proteasome inhibitor MG132 (Bachem) was done 571 
according to Liu et al.31. In brief, wild-type GA-6879 (Fig. 2a) or erg6∆32 GA-1364 (Fig. 2b) cells were 572 
grown to saturation overnight in SC proline (wild-type, SC medium without ammonium sulfate but 0.1% 573 
L-proline) or YPAD medium (GA-1364). The next morning, cells were inoculated to OD600=0.1 in SC 574 
(wild-type) or YPAD (GA-1364) proline medium supplemented with 0.003% sodium dodecyl sulfate 575 
(SDS) and grown to OD600=0.5 before addition of 75 µM MG132 or the same volume of DMSO for the 576 
control condition. After 30 min. incubation with the inhibitor, Zeocin treatment or no-damage control 577 
growth was performed for 1 hour at 30°C prior to cell harvesting for Western blot analysis. 578 
For H2B-CFP (Strain GA-3364 and derivatives) and 2-foci (Strain GA-9777) live cell 579 
fluorescent microscopy, LOG phase cells were trapped with 3 pulses of 5 psi pressure in CellASIC plates 580 
of the ONIX microfluidic perfusion system (Merck Millipore). All perfusions were done at a continuous 581 
flow rate of 2 psi pressure. After a 20-30 minute recovery phase, cells were treated for 30 minutes with 582 
the indicated amount of Zeocin prior to high-speed CFP-RFP tracking microscopy. The recovery phase 583 
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of H2B-CFP tagged cells was 20 minutes after which they were treated with a pulse of Zeocin for 1 hour 584 
and H2B-CFP fluorescence was followed for additional 40 minutes after treatment. 585 
 For constitutive H3/H4 expression or reduction experiments, GA-8386 and the relevant control 586 
strain cultures (GA-8385) were grown overnight to saturation in YP Galactose (YP Gal) or YP 587 
galactose/raffinose (YP Gal/Raff) medium and inoculated in the same respective media prior to Zeocin 588 
treatment and cell harvest. For controlled H3/H4 shutdown experiments, overnight growth and growth 589 
to OD600=0.5 was done with the same strains in YP Gal/Raff (Gal/Raff 1:5 ratio) medium which confers 590 
wild-type H3/H4 expression levels. After G1 phase arrest at 25°C with alpha factor in YP Gal/Raff 591 
medium, cells were released either into pre-warmed 25°C YP Gal or YP Raff medium for 60 minutes 592 
prior to fixation for structural illumination microscopy (SIM) or live cell high-speed imaging. 593 
In all other Western blot and label-free mass spectrometry experiments, cells were grown in full 594 
medium (YPD) and cell growth for microscopy experiments was either done in synthetic complete (SC) 595 
medium or sterile filtered, non-autoclaved YPD medium. 596 
Genome-wide nucleosome mapping 597 
Strains tested for changes in nucleosome occupancy (GA-6879 and GA-8386) were grown in 598 
appropriate media to OD600=0.8. Cultures were split into two and one of them was treated with Zeocin 599 
(500µg/ml) for 1 hour.  At this point the OD600 absorbance of each sample was measured and Candida 600 
glabrata cells were spiked in to 1/10 according to the sample OD600. Cells were washed three times with 601 
ice cold TBS (20mM Tris-HCl pH 8.0 and 150mM NaCl) and lysed by beat beating in micrococcal 602 
nuclease (MNase) digestion buffer (10 mM Tris pH 8.0, 50 mM NaCl, 5mM MgCl2, 1 mM CaCl2, 603 
1mM beta-mercaptoethanol, 0.5 mM spermidine, 0.075% NP40). The obtained chromatin samples were 604 
MNase digested to isolate mono-nucleosomes and sequencing libraries were prepared according to the 605 
method described in Wiechens et al.33. Paired end libraries of MNase digested chromatin were 606 
sequenced using illumina HiSeq technology. Fastq files containing raw reads were aligned to the S. 607 
cerevisiae and C. glabrata reference genomes by Bowtie2 with option of maximum fragment length 608 
500 for nucleosome fragments. The nucleosome dyads at each position were calculated in a defined 609 
window flanking the transcription start site (TSS). The sum of dyads at a given position across all TSS 610 
 23 
was then normalized by the total number of nucleosome dyads across all position flanking ~ 6000 TSSs 611 
in the given window. The reads were further normalized by dividing the fraction of C. glabrata reads in 612 
the sample. For low and high expression gene plots, the TSS of 15% highly and 15% lowly expressed 613 
genes were chosen. The data was smoothed using a 50 bp sliding window for graphical representation. 614 
Plots were generated with python’s plotting modules matplotlib and pylab. 615 
Quantitative Western Blot Analysis 616 
The total protein content in the relevant samples was determined with the Quant-iT protein assay kit 617 
(ThermoFisher Scientific) and 8.75 µg of total protein was loaded and run on Criterion TGX Stain-Free 618 
8-16% (Biorad) gels under SDS denaturing electrophoresis conditions. Rapid fluorescent detection of 619 
all proteins in the gel or on the membrane was done according to the manufacturer’s specifications and 620 
protein transfer on PVDF membranes was performed using the Trans-Blot Turbo system. All antibodies 621 
used for subsequent immunodetections are listed in Supplementary Table 4. Rad53 protein was 622 
detected using a custom-made mouse monoclonal antibody (GenScript) against FHA2 domain of Rad53. 623 
Anti-γH2A was similarly a custom-made polyclonal antibody, that is specific for phospho-S129 in yeast 624 
H2A. Titration curves of histone H3 and histone H4 antibodies done to work within the linear detection 625 
range prior to use (data not shown).  626 
Chromatin Fractionation and Quantitative Mass Spectrometry 627 
For SILAC based mass spectrometry, lysine and arginine double labeling of the lys2Δ arg4Δ strain yAG-628 
06A was achieved by growth for at least ten generations in “heavy” medium as described previously in 629 
Gruhler et al.34. After growth to LOG phase or at G1 cell cycle arrest, “light” labeled cells (or “heavy” 630 
labeled cells for label-swap controls) were treated for 1h with Zeocin and mixed 1:1 based on exact cell 631 
count with “heavy” labeled (“light” for label-swap control), non-treated control cells. Prior to mixing, 632 
FACS and Western blot samples were taken to test for cell cycle distribution and DDC activation. 633 
Chromatin fractionation was performed as previously described35 with the modification that 634 
chromatin obtained from SILAC labeled yeast samples was resuspended in urea buffer (50 mM Tris-635 
HCl pH 7.5, 6 M Urea, 1% SDS, 5 mM EDTA) sonicated for optimal solubilizing of proteins followed 636 
by a TCA protein precipitation step prior to downstream mass spectrometric analysis. To avoid 637 
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carbamylation in urea buffer, samples were kept below 20°C and quickly processed. Control samples 638 
from whole cell extract (WCE), supernatant (SUP) and chromatin fraction (CHR) were analyzed with 639 
SDS-PAGE (Novex 8–16% Tris-Glycine Gel, Invitrogen) gel electrophoresis followed by Coomassie 640 
staining. 641 
Samples for label-free histone quantification came from LOG phase or G1 phase arrested cells 642 
grown in YPD medium. After γIR treatment, 5 ml of culture were fixed with 10% TCA on ice. Whole 643 
cell lysates were obtained with bead-beating cells at 4°C in urea buffer (50 mM TRIS pH 7.5, 6 M Urea, 644 
1% SDS, 5 mM EDTA). 100-150 µg total protein was precipitated for downstream MS analysis. 645 
For both SILAC and label-free samples, reduction and alkylation of cysteines was performed in 646 
20 µl RCM buffer by adding 4 µl 100 mM TCEP for 30 min followed by 4 µl 250mM iodoaeetamide 647 
for another 30 min (in the dark), both at room temperature. Prior to the addition of 20 µl of 1 mg/ ml 648 
LysC (Wako, Japan) the extracts were twofold diluted to keep a final HEPES concentration of 20 mM. 649 
The first digest was performed overnight at 25°C. After 2-fold dilution, 100 µl of 0.5 mg/ ml trypsin 650 
was added and the second digest was performed at 37°C overnight. Samples were desalted using SepPak 651 
C18 columns (Waters) and eluates were dried to completion in a SpeedVac (ThermoFisher Scientific). 652 
Both SILAC and label-free LC/MS/MS analyses was performed on an Easy-nLC 1000 pump 653 
coupled to an LTQ Orbitrap Velos mass spectrometer (ThermoFisher Scientific) using a Digital 654 
PicoView ion source (New Objective). Peptides were separated on a New Objective analytical column 655 
(75 µm x 25 cm, Reprosil, 3 µm) with a 150 min. 0.1% formic acid/acetonitrile gradient. The flow rate 656 
was 200 nL/min and injection volumes were adapted accordingly for 1 µg peptides on column. 657 
Data were acquired in a Top20 data dependent analysis mode. MS scans were acquired at a resolution 658 
of 60000 over a range of m/z 350 to 1200. Label-free peptides were identified searching SwissProt using 659 
Mascot 2.4 (Matrix Science) and compiled in Scaffold 3.0 (Proteome Software). SILAC peptides were 660 
identified with MaxQuant 1.4.1.2. searching the SGD database. Two missed cleavage sites were 661 
allowed. 662 
Label-free relative quantification of histones was done by generating the extracted ion 663 
chromatogram for the peptide precursor mass, integrating the peak areas (using QuanBrowser, 664 
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ThermoFisher Scientific) which are then used for calculating the peptide ratios. The average of those 665 
ratios determines the ratio of the histones (reference untreated or wild type sample). This method is more 666 
precise than the TOP 3 TIC method used in Scaffold. Untreated or wild type references were set to 1. 667 
We used 2 peptides from each ALF, KPK1, IF4A and IFSA1 protein as internal references for the 668 
quantification of relative histone abundances in each run. Histone level ratios in SILAC samples are 669 
shown as the average from all non-label-swap or label-swap replicas. Ratios were derived from the 670 
MaxQuant peptide list taking into account only core histone peptides reported as not being subject to 671 
post translational modifications21. Significance was addressed by blotting the distribution of all protein 672 
ratios from the MaxQuant protein-groups list together with the protein intensities. Core histones were 673 
always the most abundant proteins measured and reside within the first significant interval. The 674 
MaxQuant protein-groups list was filtered by removing all contaminants, all reverse hits and proteins 675 
quantified with less than 2 peptides. The cutoff for variability was set to 30%. Normalization was done 676 
manually taking the 35 most abundant proteins (histones excluded). The MaxQuant peptide list (except 677 
for the G1 experiment) was filtered accordingly without variability cutoff and only taking peptides into 678 
account that had a L/H or H/L count greater than 3. Normalization was done manually taking the top 679 
10% most abundant peptides (histone peptides excluded). 680 
Live cell microscopy and Image Analysis 681 
Live microscopy was done on a temperature controllable Olympus IX81 microscope with a Yokogawa 682 
CSU-X1 scanning head equipped with two EM-CCD EvolveDelta (Photometrics) cameras, an ASI MS-683 
2000 Z-piezo stage and a PlanApo x100, NA 1.45 total internal reflection fluorescence microscope oil 684 
objective and Visiview software. For mRFP-GFP or mRFP-CFP high-speed tracking, fluorophores were 685 
excited with lasers at 561 nm (mCherry or mRFP) and 491 nm (GFP) or 440 nm (CFP) and emitted 686 
fluorescence was acquired simultaneously on separate cameras (Semrock FF01-617/73-25 filter for 687 
mCherry/mRFP and Semrock FF02-525/40-25 filter for GFP or Semrock FF01-475/42-25 for CFP). 688 
High-speed time-lapse series were conducted taking 8 optical slices per stack either every 80 ms for 1 689 
min or 300 ms for 2 min, with 10 ms exposure times per slice respectively. Time-lapse image stacks 690 
were analyzed as in Dion et al.9, using a custom made ImageJ (FIJI) plug-in36  to extract coordinates of 691 
locus position from the movies. Phototoxicity was tested by exposing wild-type cells (GA-6879) to 692 
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standard imaging conditions and following outgrowth for 5 h by morphological analysis, comparing 693 
them with unexposed cells. Time-series acquired from Strains GA-9227 and GA-9777 (Two-spot data) 694 
were deconvolved using Huygens Remote Manager, channel-aligned and cropped to contain one single 695 
cell/nucleus with the two respective fluorescent spots. Spot tracking over time was done with the ImageJ 696 
plugin TrackMate included in Fiji37. Boxplot graphs were generated by plotting all measured distances 697 
of treated or untreated cells. Relative MSD analysis was performed with KNIME38 using the workflow 698 
provided in the supplementary information (Supplementary Dataset 2). For each frame, the distance 699 
vector of tracks in two channels was measured by selecting the two spots with minimal distance. We 700 
performed an MSD analysis on the distance vectors for all frames and tracks with a maximum MSD(t) 701 
value bigger than 10 µm² were considered as outliers (due to mis-matching two distant tracks) and 702 
removed from the analysis. Relative MSD vs. t was averaged over all tracks and plotted using R. 703 
For H2B-CFP (GA-3364 and derivatives) live cell microscopy, cells trapped in CellASIC plates 704 
were mounted on the same microscopic setup and different stage positions of the whole field of view 705 
were excited with a 440nm laser and the emitted fluorescence was acquired on a EM-CCD EvolveDelta 706 
(Photometrics) camera using a Semrock FF01-475/42-25 emission filter. The Htz1-mEos (GA-9594) 707 
and Nup49-GFP (GA-5816) control strain was excited at 491 nm and fluorescence was recorded through 708 
a Semrock FF02-525/40-25 filter. Time-lapse series (120 min total) of 100 optical slices per stack 709 
(200nm intervals) were acquired for 12 time points at 10 min intervals, with each slice being exposed 710 
for 10 msec per laser line. Bright-field images were acquired using a CoolLED diode. Images were 711 
deconvolved using the Huygens Remote Manager software. For image analysis, deconvolved maximum 712 
intensity projections were analyzed as a merged stack in ICY. Nuclei were detected and segmented using 713 
HK means and active contours and followed through the time series. The integrated nuclear intensity 714 
was calculated for each cell nucleus and the average intensity of all single cells per condition was plotted 715 
over time. The t0 time-point to 100% intensity (via average of the first two timepoints) and the Zeocin 716 
treatment condition of each strain is shown relative to its control. 717 
Structured Illumination Microscopy and Image Analysis 718 
Structured illumination images were acquired on a Zeiss Elyra S.1 microscope with a Andor iXon 885 719 
EMCCD camera using a HR diode 488 100nW solid state laser, BP 525-580 + LP 750 filter and a PLAN-720 
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APOCHROMAT 63x N.A. 1.4 oil DIC objective lens. Cells were first fixed in PFA 4%, washed 3 times 721 
in PBS and then attached to a thin SIM grade Zeiss 1.5 glass coverslip using Concanavalin A. Cells 722 
were fully sectioned by 50-65 slices with 0.1 nm intervals taken at 60 ms exposures per slice using 5 723 
rotations of the illumination grid. Brightfield images of the cells were also acquired using an X-Cite PC 724 
120 EXFO Metal Halide lamp. Zen Black was used to process the images using automatic settings with 725 
the Raw Scale option selected. 3D stacks were then analyzed by using pixel classification and a custom 726 
Matlab script to determine the spot volumes and other features as follows. We used a fully automated 727 
nucleus and spot segmentation workflow that allowed the individual detection and feature extraction 728 
where a manual or even a semi-automated delineation would be unfeasible. The image processing 729 
software was realized within the MATLAB environment and supported by the supervised learning-730 
based pixel classification toolkit Ilastik39. The voxels corresponding to the nucleus, the inner spot and 731 
background regions are annotated interactively by brush strokes during the training phase. Features 732 
calculated at the labeled pixels and their local neighborhood are then used to train a pixel classifier based 733 
on a Random Forest ensemble learning method. The processing software provides an automated whole 734 
segmentation of all the nuclei and spots present in the scene. The image processing function is later used 735 
in a parallelized batch process on multiple processors. After detection and segmentation of nuclei and 736 
spots, the program produces a graphical output in form a maximum intensity projection with delineation 737 
of the nucleus, the spots and the unique ID integer that identifies the nucleus candidate. In addition, 3D 738 
logical masks corresponding to the classes “spot” and “nucleus” are computed. Finally, the program 739 
generates an ascii file where the key features like volume and solidity 3D and descriptive statistics are 740 
listed for all detected nuclei and foci. The solidity factor is calculated as the proportion of pixels in the 741 
3D convex hull. For statistical analysis and data representation, raw volumes were filtered to exclude 742 
spots smaller than 200 and greater than 4000 voxels, the control (Ctr.) condition was set to 1 and Zeocin 743 
treated spot or nuclei volume distributions are shown relative to the untreated control. The distributions 744 
were plotted with R as boxplot graphs or a cumulative density functions. 745 
Microscopy and Image Analysis of Fixed Samples 746 
Microscopy of fixed GA-9777 samples was done with the same Olympus IX81 microscope setup 747 
mentioned before. Cells were fixed with paraformaldehyde and attached to a thin SIM grade Zeiss 1.5 748 
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glass coverslip using Concanavalin. We acquired 70 optical slices in 100nm intervals with the 561 nm 749 
and 491 laser line (130 ms exposure each). Bright-field images were acquired using a CoolLED diode. 750 
Images were deconvolved using Huygens Remote Manager, channel-aligned and 3D inter-spot distances 751 
(∆d) between the GFP and mRFP centroids were measured with the Imaris software. The distribution of 752 
all measured distances per condition was plotted with R as a boxplot graph or a cumulative density 753 
function. 754 
Ectopic Recombination Assays  755 
For Fig. 8a: As used in wild-type cells, arp8∆ cells and cells depleted for NHP6A/NHP6B 756 
For specific growth conditions, please consult the “Yeast growth, cell cycle arrests and flow cytometry” 757 
section. Equal amounts of exponentially growing wild-type (GA-6879) arp8∆ (GA-8132) and nhp6∆ 758 
(GA-9771) were transformed with the transformation protocol either with a linearized URA3 plasmid 759 
(pRS406 cut with StuI) presenting 800 bp homology to the W303 ura3-1 locus or a mgs1::caURA3 PCR 760 
fragment (template plasmid #1050) presenting 40 bp and 42 bp upstream and downstream homology to 761 
the MGS1 locus. As a control, the centromeric circular plasmid #2422 (ADE2, hphMX4, Cen/ARS), 762 
which is maintained in yeast cells ectopically, was transformed alongside with the URA3 integration 763 
cassettes. Primers were #7297: 764 
(GTTTTTTTACGCTTGAGGCGCATTGCATTGCTGGCACGTTTTTGTGCGGATCC 765 
CCGGGTTAATTAA) and #7298: 766 
(CGTATATGTTCTAATATATCTCAGATGGGCCCGCGAGACTTTGCGCGTTGGCCGATTCAT767 
TA). 768 
After transformation, cells were split and plated on SC-URA plates (100 µl) to select for transformants 769 
resulting from integration and on and YPD + Hygromycin B plates to select for cells containing the 770 
plasmid. The numbers of Ura+ and Leu+ transformants obtained from each reaction were compared to 771 
calculate the relative integration rate for each strain, with that of a wild-type strain arbitrarily set to 1 as 772 
a reference. Growth was scored in biological quadruplicates and each transformation was done with four 773 
technical replicates.; results were averaged. 774 
For Fig. 8c-d: “Ctr.” cells and Gal:H3/H4 “histone shutdown” cells 775 
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For specific growth conditions, please consult the “Yeast growth, cell cycle arrests and flow cytometry” 776 
section. After pre-growth in YP Galactose/Raffinose 1:5 medium, equal amounts of exponentially 777 
growing control (GA-8385) and Gal:H3/H4 “histone shutdown” (GA-8386) cells were pulse-reduced 778 
for histone H3 and H4 levels via 2 hour growth in either YP Galactose/Raffinose 1:20 or YP Raffinose 779 
medium. After the histone-reduction pulse, transformations were done with either an atg2::hphMX4 780 
PCR fragment (PCR product – ATG2::hygro, template plasmid #1049) presenting 40 bp and 40 bp 781 
upstream and downstream homology to the ATG2 locus or a mgs1::hphMX4 PCR fragment (PCR 782 
product – MGS1::hygro, template plasmid #1049) presenting 40 bp and 42 bp upstream and downstream 783 
homology to the MGS1 locus. As a control, the centromeric circular plasmid #282 (LEU2, Cen/ARS), 784 
which is maintained in yeast cells ectopically, was transformed alongside with the hphMX4 PCR 785 
integration cassettes. 786 
Primers for PCR product – ATG2::hygro were #6302: 787 
(ATAGCCTTGGCGAGTTTTCCGTACATTGAAGAATTCGCCAAGCGGATGCCGGGAGCAGA788 
C) 789 
and #6303: 790 
(GGGATTTTTGGCTCAAGGTGTGGTGGCCCCTTTTCTAAGGGTGAGCTGATACCGCTCGCC) 791 
Primers for PCR product – MGS1::hygro were #7297: 792 
(GTTTTTTTACGCTTGAGGCGCATTGCATTGCTGGCACGTTTTTGTGCGGATCCCCGGGTTA793 
ATTAA)  794 
and #7298: 795 
(CGTATATGTTCTAATATATCTCAGATGGGCCCGCGAGACTTTGCGCGTTGGCCGATTCAT796 
TA). 797 
After transformation, cells were split and plated on YPGal +Hygromycin B plates (100 µl plated) to 798 
select for transformants resulting from integration of ATG2::hygro or MGS1::hygro and on and SCGal 799 
-LEU plates (10 µl plated) to select for cells containing the plasmid. The numbers of hphMX4+ and 800 
LEU+ transformants obtained from each reaction were compared to calculate the relative integration 801 
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rate for each strain, with that of a wild-type strain arbitrarily set to 1 as a reference. Growth was done in 802 
biological quadruplicates and each transformation was done with four technical replicates; results were 803 
averaged. 804 
Recovery assay 805 
Equal amounts of exponentially growing (YPAD medium, cell density approx. 1x107 cells/ml) WT (GA-806 
6879), arp8∆ (GA-8132), nhp6∆ (GA-9771) and arp8∆nhp6∆ cells (GA-9815) were treated in 807 
triplicates with increasing amounts of Zeocin (100, 250 and 500 µg/ml). After 1 hour of treatment, cells 808 
were washed once with fresh, pre-warmed (30°C) YPAD medium and grown for an additional hour in 809 
YPAD without Zeocin. After this step, the cell density was accurately determined in three technical 810 
replicates and used as a later correction factor for cell growth within the 1 hour of Zeocin treatment and 811 
the 1 hour growth in YPAD of the control (Ctr.) versus the Zeocin treated cultures (Zeo100 – Zeo500). 812 
Aliquots were removed and plated in a dilution row. Growing colonies vs. plated cells were quantified, 813 
the Ctr. situation served as reference point and was set to 100%. 814 
Rad52-YFP Recovery Assay 815 
Cells grown to saturation overnight in sterile filtered, non-autoclaved YPD medium were diluted the 816 
next morning and the experiment was started when reaching OD600=0.6. Wild type (GA-9772) and 817 
nhp6∆ cells (GA-9771) were treated with 250 µg/ml Zeocin for 30 minutes. Zeocin was washed away 818 
and Rad52-YFP foci formation was followed over a total time-course of 16 hours taking microscopic 819 
images at the following time points: 0 min, 20 min, 40 min, 1h, 2h, 4h, 6h, 8h, 10h, 12h, 14h and 16h. 820 
Rad52-YFP foci were imaged with the same microscopic setup as mentioned above acquiring 50 optical 821 
slices in 200 nm intervals with 50 ms exposure time using a 514 nm laser with appropriate emission 822 
filters. Images were deconvolved as described above, maximum intensity projected and the binary (+ or 823 
-) content of Rad52-YFP foci all living cells at each time point in each strain was counted. The average 824 
amount of Rad52-YFP foci containing cells per time point was plotted and is shown together with a 825 
logarithmic fit. 826 
Estimating the anomalous diffusion exponent α and the diffusion coefficient 827 
Please refer to Supplementary Notes. 828 
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Estimating the effective spring coefficient ck  829 
Please refer to Supplementary Notes. 830 
Statistics and Reproducibility 831 
All chromatin mobility data (spot tracking) are pooled from three independent experiments (Fig. 3a, 832 
Fig. 5d, Fig. 6cd, Supplementary Fig. 5a). Statistical analysis testing the significance of the 833 
biophysical parameters derived from the imaging data was performed with Matlab using the 834 
Kolmogorow-Smirnow-Test (Fig. 3b, Fig. 5d, Fig. 6e, Supplementary Fig. 5b, Supplementary Fig. 835 
7cd). All SIM microscopy data from individual single cells are pooled and were derived from one 836 
experiment. The data was analysed with RStudio using unequal variance t-tests (Fig. 3d, Fig. 5c, Fig. 837 
6f, Fig. 7d). For H2B-CFP single cell fluorescent microscopy analysis, the integrated nuclear intensity 838 
was calculated for each cell nucleus and the average intensity of all single cells per condition was plotted 839 
over time. All data from single cells originating from three independent cultures on three different days 840 
(Fig. 1d H2B-CFP); two independent cultures on two different days (Fig. 1d Htz1-mEos, Fig. 7c 841 
rad51∆/sml1∆/arp8∆); two independent cultures from the same day (Fig. 7c rad53∆sml1∆). 842 
Recombination efficiency and cell recovery experiments were performed in triplicates (three 843 
independent cell cultures) and Excel was used to perform two-tailed student’s t-tests (Fig. 8 abd). 844 
Chromatin fractionations were repeated with three independent cultures (Supplementary Fig. 1fg) or 845 
two independent cultures (Fig. 1a, Supplementary Fig. 1h, Supplementary Fig. 3ij). Nucleosome 846 
mapping data for the wild-type strain (GA-6879) was performed on four independent cultures (Fig. 1c, 847 
Supplementary Fig. 2e); for the H3/H4 transcription independent strain (GA-8386) the experiment was 848 
done once (Supplementary Fig. 4b) but new data deriving from four independent cultures shows the 849 
same effect (data not shown). The kinetics of the Rad52-YFP recovery assay on wild-type and nhp6∆ 850 
cells (12 different time-points) was performed once but done on the single cell level. 851 
Data availability statement 852 
The EBI project ID for the nucleosome-Seq data in this study is PRJEB14701. Source data for Figs. 853 
1bd, 2abc, 5b, 7bc, 8a, Supplementary Fig. 2g and mass spectrometry data (Supplementary Dataset 4-854 
9) are available with the paper online. Other data supporting the findings of this study are available from 855 
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the corresponding authors upon request. 856 
 857 
References (Online Methods only) 858 
30. Haase, S.B. & Lew, D.J. Flow cytometric analysis of DNA content in budding yeast. Methods 859 
Enzymol 283, 322-32 (1997). 860 
31. Liu, C., Apodaca, J., Davis, L.E. & Rao, H. Proteasome inhibition in wild-type yeast 861 
Saccharomyces cerevisiae cells. Biotechniques 42, 158, 160, 162 (2007). 862 
32. Lee, D.H. & Goldberg, A.L. Selective inhibitors of the proteasome-dependent and vacuolar 863 
pathways of protein degradation in Saccharomyces cerevisiae. J Biol Chem 271, 27280-4 864 
(1996). 865 
33. Wiechens, N. et al. The Chromatin Remodelling Enzymes SNF2H and SNF2L Position 866 
Nucleosomes adjacent to CTCF and Other Transcription Factors. PLoS Genet 12, e1005940 867 
(2016). 868 
34. Gruhler, A. et al. Quantitative phosphoproteomics applied to the yeast pheromone signaling 869 
pathway. Mol Cell Proteomics 4, 310-27 (2005). 870 
35. Pasero, P., Duncker, B.P., Schwob, E. & Gasser, S.M. A role for the Cdc7 kinase regulatory 871 
subunit Dbf4p in the formation of initiation-competent origins of replication. Genes & 872 
Development 13, 2159-2176 (1999). 873 
36. Sage, D., Neumann, F.R., Hediger, F., Gasser, S.M. & Unser, M. Automatic tracking of 874 
individual fluorescence particles: application to the study of chromosome dynamics. IEEE 875 
Trans Image Process 14, 1372-83 (2005). 876 
37. Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat Methods 9, 877 
676-82 (2012). 878 
38. Dietz, C. & Berthold, M.R. KNIME for Open-Source Bioimage Analysis: A Tutorial. Adv Anat 879 
Embryol Cell Biol 219, 179-97 (2016). 880 
39. Sommer, C. & Gerlich, D.W. Machine learning in cell biology - teaching computers to 881 
recognize phenotypes. J Cell Sci 126, 5529-39 (2013). 882 
 883 
 884 
Figure 1
a
c
d
b
H3
H4
γH2A
Rad53 *
MCM2
Ctr.
Zeo
Ctr. 50 200 500 750
µg/mlWB
analysismix
1:1
Heavy
Light
Zeo250
fractionate 
chromatin
LC-MS/MS
analysis
Asynchronous (label swap)
0.5 
1 
1.5 
allpeptides  
H2A 
H2B 
H3 
H4 
Htz1
# of
peptides3751884 3 3
1h Zeo
Ctr.
Asy.
culture
Nucleosome occupancy
in
di
vid
ua
l c
el
ls
+ Zeo
- Zeo
Re
la
tiv
e 
pe
pt
id
e 
ra
tio
s 
L/
H
+Zeo300 wash out
80 min 120 min20 min
0
0,2
0,4
0,6
0,8
1
1,2
Ctr. (n=178)
Zeo (n=50)
Time imaged (min)
20 40 60 100 12080
Htz1-mEoS
%
  
uo
re
sc
en
t  
si
gn
al
0
0,2
0,4
0,6
0,8
1
1,2
Ctr. (n=69)
Zeo (n=153)
Time imaged (min)
20 40 60 100 12080
H2B-CFP
H
2B
-C
FP
H
tz
1-
m
Eo
S
20 min 80 min 120 min
MNase
seq
reads Ctr.
Zeo500
0.0010
0
Distance from TSS (bp)
-500 500 1000-1000
0.0015
0.0020
0.0025 Low expression genes
Asy. culture
All genes
Asy. culture (WT)
Ctr.
Zeo500
0
Distance from TSS (bp)
-500 500 1000-1000
0.0035
0.0030
0.0025
0.0020
0.0015
0.0010
0.0005
N
or
m
.  
nu
cl
eo
so
m
e 
re
ad
s
Ctr. 50 100 200 500
H3 H4
750
Zeocin concentration (µg/ml)
%
 H
is
to
ne
s 
(r
el
at
iv
e 
to
 C
tr
.) H3 & H4 levels
0.0
0.5
1.0
Figure 2
*
*
a
c
b
%
  H
3 
si
gn
al
 (r
el
at
iv
e 
to
 C
tr
.)
%
  H
4 
si
gn
al
 (r
el
at
iv
e 
to
 C
tr
.)
%
  H
4 
si
gn
al
 (r
el
at
iv
e 
to
 C
tr
.)
MG132DMSO
Asy.
culture
H3
γH2A
Ctr.
Actin
MG132 MG132
wild type strain
erg6∆ = increased membrane
permeability for MG132
Zeo300
+
++
- +-
--
pre1-1, pre2-2
pr
e1
-1
pr
e2
-2W
T
++
WT
--
Ubi
250
KDa
150
100
MG132
Zeo300
+
++
MG132
Zeo500
+
++
Zeo500++
-
± Zeo ± Zeo
H4
H4
Rad53
γH2A
Actin
Rad53
γH2A
Zeo500
++ --Zeo500
erg6∆ strain
Proteasome
dysfunction
0.0
0.2
0.4
0.6
0.8
1
1.2
0.0
0.2
0.4
0.6
0.8
1
1.2
0.0
0.2
0.4
0.6
0.8
1
1.2
Figure 3
a
dc
b
x
y
z
3D
2D
Track TetR-mCh over time
Rad52-YFP
Z-
pr
oj
ec
t
met10
MET10
locus
Tel6R
60kb 71kb
Cen6
+GFP-Nup49TetR-mCh/TetO
+Rad52-YFP
undamaged
ce
ll 
co
un
t
G1
S
Asy.
1N 2N + α
-fa
cto
r
15’
30’
90’
rel
ea
se
0 10 20 4030 50 60
MET10 locus0.00
0.10
0.15
0.20
0.05
M
SD
 (µ
m
)2
∆t (s)
Zeo500
Zeo200
Ctr.
Chromatin mobility S phase
***
***
Re
la
tiv
e 
Te
tR
-m
Ch
er
ry
 v
ol
um
e
n=
879
n=
300
n=
451
S
Zeo500
Zeo200
Ctr.
0.5
1.0
1.5
2.0
nuc
leus
SIM imaging
Fixed cells
± Zeo
3D pixel
classication
Generate 3D map
measure volume
x
y
z
*
***
Condensation
Anomalous exponent α
0.5 0.6 0.7 0.8 0.9
dense open
*****
0
Constraining forces
 kC (kBT/µm
2)
50 100 150 200
loose tight
*NS
Diusion
slow fast
DC (µm
2/sec) x 10-3
1 2 3 4 5
Zeo500
Zeo200
Ctr.
*****
Connement
small large
 LC (µm)
0.1 0.15 0.2 0.25 0.3 0.35
∆t = 300 ms 
+Zeo500
Imaged:
Track TetR-mCh in Rad52-
YFP positive cells
80 ms intervals for 1 min
   or
300 ms intervals for 2 min
Figure 4
a b
3D3D
∆d
∆d (GFP-RFP) ± Zeo in xed cells
CHR XIV
320 kbp Tel14RTel14L Cen14
TetR-mRFP/TetOGFP-LacI/LacO
+Rad52-GFP
CHR III
50 kbp
tracks
Tel3RTel3L Cen3
TetR-mRFP/TetOCFP-LacI/LacO
Zeo500Ctr.
n=
3,669
n=
7,177
***
0.0
0.5
1.0
1.5
3D
 in
te
r−
di
st
an
ce
 C
FP
-R
FP
 (µ
m
)
3D
  i
nt
er
−d
is
ta
nc
e 
G
FP
-R
FP
 (µ
m
) *** *
n=
252
n=
210
n=
158
n=
152
G1 S S
0.5
0.0
1.0
1.5
2.0
2.5
+ Zeo
+ Zeo
- Zeo
- Zeo
∆d (CFP-RFP) ± Zeo over time
Imaged: 300 ms intervals for 1min
2µm
2µ
m
z
x
y0
nucleus
2.6
2.7
2.8
1.9
2.0
2.1
2.2
2.0
2.2
2.4
2.6
z 
po
st
io
n 
[µ
m
]
x postion [µm]
y p
os
tio
n [
µm
]
RFP spot
CFP spot
tim
e
0 10 3020 40
0.0
0.2
0.3
0.1
Re
la
tiv
e 
M
SD
 (µ
m
)2
∆t (s)
Zeo500
Ctr.
S phase
G1
S
3D inter−distance [µm]
cu
m
m
ul
at
iv
e 
pr
ob
ab
ili
ty
cu
m
m
ul
at
iv
e 
pr
ob
ab
ili
ty
0.0 0.5 1.0 1.5 2.0
0.0
0.2
0.4
0.6
0.8
1.0
0.0 0.5 1.0 1.5 2.0
0.0
0.2
0.4
0.6
0.8
1.0
∆t = 300 ms 
CFP-lacI - TetR-RFP
Figure 5
a
c
d
b
MGS1
G1 arrest 60 min. release into S
0 10 20 30 40
0.00
0.10
0.15
2.00
0.05
∆t (s)
SD (Gal)
SD (Ra)
Control (Ra)
0 10 20 30 40
0.00
0.10
0.15
2.00
0.05
M
SD
 (µ
m
)2
∆t (s)
Control (Gal)
SD (Ra)
    H3/H4
URA
HHT1 HHF1
HHF2HHT2
   H
3/H
4
Trp
HHT1 HHF1
HHF2HHT2
Control Shutdown (SD)
389 kbp240kbp
Tel14RTel14L Cen14
GFP-LacI/LacO
MGS1
Control strain Shutdown strain
GA
L::
G1 G2/MS
+ α-factor
90minLOG 60 min 60 min.
Release in Ra or Gal 
0.0 0.5 1.0 1.5 2.0 2.5
0.
0
0.
4
0.
8
1.
0
Relative GFP-LacI volume
cu
m
m
ul
at
iv
e 
pr
ob
ab
ili
ty
+ Ra
+ Ra
NS
***
Re
la
tiv
e 
G
FP
-L
ac
I v
ol
um
e
S phaseG1 phase
0.
0
0.
5
1.
0
1.
5
2.
0
2.
5
0.0
0.5
1.0
1.5
2.0
2.5
H3/H4
stable
H3/H4
stable
H3/H4
stable
H3/H4
reduced
H3/H4
stable
H3/H4
reduced
release in S
G1 arrest
time after 
release in Ra (min)
H4 levels
Control SD strain
0
1
2
0
30
60
120
180
%
 H
4 
(r
el
at
iv
e 
to
 W
T)
+ Gal
∆t = 80 ms 
MGS1
∆t = 80 ms 
Shutdown
strain
n=
127
n=
160
n=
179
n=
279
Figure 6
a b c
f
nhp6∆
less nucleosomes on DNA
WT
WT level of nucleosomes
WT nhp6∆
WB- H4 levels
1
0.2
0.4
0.6
0.8
%
 H
4 
(re
la
tiv
e 
to
 W
T)
1N 2N
nhp6∆
WT
WT
nhp6∆
WT
nhp6∆
*** * *
Re
la
tiv
e 
Te
tR
-m
Ch
 v
ol
um
e
n= 
356
n=
187
n=
325
n=
190
n=
154
n=
123
Asy. G1 S
0.5
1.0
1.5
2.0
2.5
0
0.00
10 20 30 40
0.10
0.15
2.00
0.05
M
SD
 (µ
m
)2
∆t (s)
MET10 locus
MET10 locus
S phase S phase
0
0.00
10 20 30 40
0.10
0.15
2.00
0.05
M
SD
 (µ
m
)2
∆t (s)
PES4 locus
d
e
∆t = 80 ms ∆t = 80 ms
75 12525
Constraining forces
loose tight
M
ET
10
PE
S4
75 12525
 kC (kBT/µm
2)
**
NS
Figure 7
Zeo500
Ctr.
n=
508
n=
406
n=
296
n=
373
n=
377
n=
235
n=
841
n=
710
arp8∆mec1∆
sml1∆
NS NS
sml1∆rad51∆
n=
885
n=
751
0.5
1.0
1.5
2.0
2.5
re
la
tiv
e 
Te
tR
-m
Ch
er
ry
 v
ol
um
e
WT
S phase
****** ***
%
  
uo
re
sc
en
t  
si
gn
al
b c
d e
Ctr. (n=70)
Zeo (n=74)
Time imaged (min)
20 40 60 100 12080
H2B-CFPsml1∆  +
Ctr. (n=246)
Zeo (n=235)
Time imaged (min)
20 40 60 100 12080
H2B-CFPrad53∆sml1∆  +
Ctr. (n=70)
Zeo (n=83)
Time imaged (min)
20 40 60 100 12080
H2B-CFParp8∆  +
0
0,2
0,4
0,6
0,8
1
1,2
Ctr. (n=199)
Zeo (n=303)
Time imaged (min)
20 40 60 100 12080
H2B-CFPrad51∆  +
a
H3
H4
Rad53
Zeo500
Tub1
+- +- +- +- +- +- +- +-
WT
rad53∆ 
sml1∆
mec1∆
 sml1∆sml1∆exo1∆
Local repair
rad51∆ arp8∆ ies4∆ arp5∆
*
+-
swr1∆
+-
Act
checkpoint INO80-C
%
  H
4 
(re
l. 
to
 C
tr
.)
H4 levels after damage
0.0
0.5
1.0
W
T
rad53∆ sml1∆
mec1∆ sml1∆
sml1∆
arp8∆
ies4∆
SWR1-C
DNA damage
DDC activation (Mec1, Rad53)
Histone loss (INO80-C)
Chromatin
decompaction & enhanced mobility
Repair
Damage
Histone
degradation
Chromatin
expansion
-less nucleosomes on DNA
-chromatin more accessible
Figure 8
PCR product  
Linearized Plasmid
arp8∆ nhp6∆R
el
at
iv
e 
in
te
gr
at
io
n 
ra
te
WT
***
***
*
*
a b
3
4
2
1
0
Integration assay Recombination eciencies
URA3
***
***
***
PCR product - ATG2::hygro  
PCR product - MGS1::hygro
Re
la
tiv
e 
in
te
gr
at
io
n 
ra
te
Integration assay
Hygro
0
1
2
3
4
Gal.:Ra. pulse
0
1
2
3
4
5
 Ra. pulse
Ctr.Ctr. SD SD
Locus being targeted
(ATG2 or MGS1) 
Locus being targeted
(MGS1 or ura3-1) 
dc
URA
HHT1 HHF1
HHF2HHT2
   H
3/H
4      
Trp
HHT1 HHF1
HHF2HHT2
Control Shutdown (SD)
GA
L::
120 minLOG Integration Assay
Pulse
Gal.:Ra. or Ra. 
After pulseBefore pulse
Recombination eciencies
%
 re
co
ve
ry
 (l
og
10
)
Zeocin concentration
Cell recovery from Zeocin
1
10
0.1
0.01
0.001
Ctr. Zeo100 Zeo250 Zeo500
nhp6∆
WT
arp8∆
nhp6∆
arp8∆
Supplementary Items List  
 
Note that we do NOT copy edit or otherwise change supplementary information, and 
minor (nonfactual) errors in these documents cannot be corrected after publication. 
Please check carefully for errors.  
 
Journal: Nature Structural & Molecular Biology 
 
Article Tracking 
Number: 
NSMB-A36792A 
Article Title: Histone degradation in response to DNA damage enhances chromatin 
dynamics and recombination rates 
 
Corresponding 
Author: 
Susan M. Gasser (Susan.gasser@fmi.ch) 
 
Supplementary items submitted in combined files 
 Please enter numbers below 
Number of Supplementary Figures 
submitted in Integrated Supplementary 
Figure template 
7 
Number of Supplementary Tables 
submitted in combined PDF file 
4 
Number of Supplementary Notes submitted 
in combined PDF file 
1 
 
 
Supplementary items submitted in additional files  
(e.g., Videos, Data Sets and Excel Tables) 
Please list items, titles and captions below, following the examples shown 
Supplementary 
Item & Number 
Title and Caption 
Supplementary 
Video 1 
H2B-CFP intensity decreases in response to DNA damage. 
Visualization of data shown in Fig. 1d. Exemplary time course of 9 
individual cells following H2B-CFP intensities after 60 min (20 
min – 80 min time point) treatment with 300 µg/ml Zeocin for a 
total time of 120 min. Shown is a merge of Brightfield (average 
intensity projections) and CFP (maximum intensity projection) 
channels. Time-lapse series (120 min total) of 100 optical slices per 
stack (200nm intervals) were acquired for 12 time points at 10 min 
intervals, with each slice being exposed for 10 msec per laser line. 
Video was generated with Fiji (ImagJ) and is shown at 2 frames per 
second. Original ∆t is shown in the top right corner. 
Supplementary 
Video 2 
CFP-LacI, TetR-mRFP time-course used for live cell 3D inter-
distance measurements. Visualization of data shown in Fig. 4b. 
Exemplary time course of CFP-LacI and TetR-mRFP used for 3D 
inter-distance measurements in living cells. The fluorescent 
channels were acquired simultaneously on two different CCD 
cameras; taking 8 optical slices (200nm thickness) per stack every 
300 ms for 2 min, with 10 ms exposure times per slice respectively. 
Video was generated using the Imaris 8.2.0 software and is shown 
at 25 frames per second (7.5x faster than the original acquisition 
speed). 
Supplementary 
Dataset 1 
Uncropped Immunoblot images. Uncropped blot images used in 
Fig.  1b, 2a, 2b, 2c and 7a 
Supplementary 
Dataset 2 
Summary of mobility parameters. Table showing the strains, 
conditions and mobility parameters. 
Supplementary 
Dataset 3 
KNIME workflow. File contains the KNIME workflow used for 
imaging data analysis. 
Supplementary 
Dataset 4 
MS search results peptides table cycling cells label swap. File 
contains MaxQuant search results used for quantifications. 
Supplementary 
Dataset 5 
MS search results protein groups table cycling cells label swap. 
File contains MaxQuant search results used for quantifications. 
Supplementary 
Dataset 6 
MS search results peptides table cycling cells non label swap. 
File contains MaxQuant search results used for quantifications. 
Supplementary 
Dataset 7 
MS search results protein groups table cycling cells non label 
swap. File contains MaxQuant search results used for 
quantifications. 
Supplementary 
Dataset 8 
MS search results peptides table G1 arrest cells. File contains 
MaxQuant search results used for quantifications. 
Supplementary 
Dataset 9 
MS search results protein groups table G1 arrest cells. File 
contains MaxQuant search results used for quantifications. 
 
 
 
 
Supplementary Figure 1 
SILAC mass spectrometry of pre-enriched chromatin depicts core histone loss 
(a) Experimental workflow for SILAC mass spectrometry after Zeocin treatment. (b) Labeling and mixing of samples from 4 individual 
experiments. Asterisks indicates label swap (c) Colloidal Commassie stained SDS-PAGE of SILAC experiment replicas showing total 
protein, supernatant (SUP), and chromatin (CHR) fractions from a. His. mix is an equimolar mixture of recombinant Histone H2A, H2B, 
H3 and H4. (d) Control Immunoblot analysis using anti-γH2A anti-Rad53 antibodies to show that checkpoint is activated after Zeocin 
treatment in the SILAC samples from bc. (e) FACS analysis showing that all samples from b-d have similar cell cycle profiles. Actin was 
used as loading control. Asterisks indicate the phosphorylation-dependent mobility shift of Rad53. (f) SILAC mass spectrometry on 
chromatin fractions from three independent cell pools. Boxplots show heavy/light histone peptide distribution indicating the degradation 
of core histones and, to a lesser extent, Htz1 (H2A.Z). (g) Distribution of measured protein ratios in the non-label swap experiment or (h) 
label swap experiment. Core histones are labelled red and reside within the µ-σ range. Htz1 is labelled yellow resides closer to the mean 
ratio of all proteins. Boxplots in f represent median values, interquartile ranges and whiskers. 
 
 
 
 
Supplementary Figure 2 
Gamma radiation triggers degradation of core histones. Zeocin reduces nucleosome occupancy. H2B-CFP tagging does not 
interfere with cell viability 
(a) Immunoblot analysis from one experiment using H3 and H4 specific antibodies on whole cell extracts of asynchronous WT cells 
exposed to 30 Gy gamma irradiation (γ-IR). Rad53 and γH2A were probed to confirm checkpoint activation. MCM2 was used to control 
for loading. Arrows indicate samples sent for label-free quantitative mass spectrometric analysis. (b) Label-free quantitative mass 
spectrometry results of samples depicted in a. Bar graphs show mean peptide ratios ± s.e.m for the indicated histone proteins upon γIR 
exposure relative to the control condition. (c) Combined label-free mass spectrometry results of sample γ-IR a), γIR b) and an additional 
experiment. Bar graphs represent the mean peptide ratios (γIR/Ctr.) ± s.e.m. for core histones over all samples. (d) FACS analysis 
showing that all samples have similar cell cycle profiles. (e) Genome-wide nucleosome mapping  graph shows the distribution of 
nucleosome reads over 750 highly expressed genes aligned to their TSS from four independent experiments (±s.d. is shaded). (f) Drop 
assay control showing that the H3-CFP fusion complements the absence of H3 in response to genotoxic agents. (g) Live single-cell 
microscopy of Nup49-GFP. Graph shows the the mean fluorescent signals of of all individual cells (cell numbers indicated in graph) per 
treatment over time relative to the control (Ctr.) condition. 
 
 
 
 
 
Supplementary Figure 3 
Damage-induced histone loss occurs in G1 phase 
(a-b) Representative immunoblot analysis of whole cell extracts from G1-arrested cells treated with Zeocin a or after exposure to γIR b. 
Histone H3 and H4 levels were probed using histone specific antibodies. Rad53 and γH2A were probed to confirm checkpoint activation. 
MCM2 was used to control for loading and Ctr. represents bands on the ponceau stained membrane. Bar graphs in a show the mean ± 
s.e.m. over three independent replicates relative to the control condition. FACS results of Zeocin treated samples are shown above 
immunoblots in a. Arrows in b indicate samples sent for label-free quantitative mass spectrometric analysis. (c) Immunoblot 
quantifications of irradiated samples from one experiment marked with arrows. (d) Label-free quantitative mass spectrometry results of 
samples depicted with arrows. Bar graphs show mean peptide ratios ± s.e.m. for the indicated histone proteins upon γIR exposure relative 
to the control condition. (e) FACS analysis showing cell cycle profiles of all samples from b. (f) Experimental workflow for SILAC mass 
spectrometry of G1 arrested cells after Zeocin treatment. (g) Commassie stained SDS-PAGE of samples showing total protein, 
supernatant (SUP), and chromatin (CHR) fractions. (h) FACS analysis showing similar G1 arrest efficiency for all samples. (i) SILAC 
mass spectrometry on chromatin fractions from two independent cells pools. Boxplots show heavy/light histone peptide distribution 
indicating the degradation of core histones and, to a lesser extent, Htz1 (H2A.Z). (j) Distribution of measured proteins ratios. Core histones 
are labelled red and reside within the µ-σ range. Htz1 (H2A.Z) is labelled yellow and residues closer to the mean ratio of all proteins. 
Boxplots in i represent median values, interquartile ranges and whiskers. Asterisk indicates phosphorylation-dependent Rad53 mobility 
shift. 
 
 
 
 
Supplementary Figure 4 
Damage-induced histone loss is independent of histone transcription 
(a) Top panel shows experimental procedure and strain schematic for constitutive histone H3 and H4 transcription in cells grown 
YPGal:Raff medium. A plasmid borne construct in which the GAL1/10 promoter drives the only pair of histone H3/H4 genes is used. Mid 
panel shows representative immunoblot analysis using anti-H3 and anti-H4 antibodies on whole cell extracts from the strain depicted in 
a after Zeocin treatment and growth in YPGal:Raff medium. Rad53 and γH2A were probed to confirm checkpoint activation. MCM2 was 
used to control for loading and Ctr. represents bands on the original gel (UV-TGX stained). Bar graphs in bottom panel show the mean ± 
s.e.m. over three independent replicates relative to the control condition. Asterisk indicates phosphorylation-dependent Rad53 mobility 
shift. (b) Zeocin treatment causes a genome-wide decrease in nucleosome occupancies. Data represents nucleosome occupancies over 
the total pool of 5014 protein coding genes, 750 high expression genes and 750 low expression genes aligned to their transcriptional 
start site (TSS) from one experiment using the strain depicted in a. 
 
 
 
 
Supplementary Figure 5 
High-speed, live cell imaging reveals increase in chromatin movement and loss of constraining forces following DNA damage 
(a) High-speed (Δt=80 ms) imaging of the undamaged MET10 locus (as in Fig. 3a-b) showing that chromatin mobility increases with 
Zeocin concentration. Average MSD graphs indicate dose-dependent increases in global chromatin mobility in response to DNA damage 
(nCtr.=39, nZeo200=31, nZeo500=29 different cells from three independent experiments). (b) Graphs show the medians and whiskers of 
biophysical parameters derived from imaging data and predict chromatin decompaction after Zeocin treatment. P-values, ***P<0.001, 
NS=not significant, result from Kolmogorow-Smirnow-tests. All MSD graphs represent the mean ± s.e.m. of cells pooled from three 
independent experiments. Additionally, consult Supplementary Dataset 2 for mobility parameters and the number of cells analyzed. 
 
 
 
 
 
 
Supplementary Figure 6 
GAL::H3/H4 strain as a tool for in-vivo artificially controlled histone level reductions 
(a) Schematic representation of wild-type, control and shutdown strains grown in the indicated media. Gal. = galactose, gluc. = glucose. 
Immunoblot analysis of whole cell extracts of the indicated conditions and strains were performed using an antibody directed against 
Histone H4. Rad53 and γH2A were probed to confirm checkpoint activation. MCM2 was used to control for loading. Bar graphs from 
quantified immunoblot derived from one experiment shows overexpression or reduction of H3/H4 in the shutdown strain grown in gal. or 
gluc. medium respectively. Growth of the shutdown strain in Gal:Raff 1:5 confers H3/H4 levels similar to WT. (b) Experimental workflow 
of the arrest-release experiment used to reduce histone levels in S phase (as in Fig. 5). Bar graphs from quantified immunoblot data 
derived from one experiment shows reductions of H3 and H4 upon release into raffinose medium. (c) A defined number of exponentially 
growing cells (fivefold dilutions) was spotted on different YP or YPD plates containing the indicated dose of hydroxyurea (HU). Cells 
exposed to 20 Gy γIR were spotted onto YPD plates.  Drop assays show functionality of shutdown and control strains. Control = control 
from a, control 1 and 2 = similar to control 1 but expressing HHT2-HHF2 from a URA plasmid. 
 
 
 
 
Supplementary Figure 7 
Biophysical parameters of nhp6∆ tracking data and results from Rad52-YFP recovery assay 
(a) Control Immunoblot from one experiment (loading 1x and 2x the volume) showing that nhp6Δ strains do not have constitutive 
checkpoint activation. Rad53 was probed to test for checkpoint activation and MCM2 was used as loading control. (b) Schematics of the 
strains used for imaging the PES4 and MET10 loci (Fig. 6c-e) with representative images. Scale bar is 2 µm. (c-d) Graphs show the 
medians and whiskers of biophysical parameters derived from imaging data of PES4 c and MET10 d (Fig. 6c,d). P-values, P*P<0.05, 
***P<0.001, NS=not significant, result from Kolmogorow-Smirnow-Tests. (e) Rad52-YFP foci recovery assay. Graph shows the overall 
percentage of Rad52-YFP foci containing cells for each of the 12 time-points from one experiment plotted against the time and shown 
together with a logarithmic fit. 
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Supplementary Tables 
Nucleosome mapping sequencing reads 
Supplementary Table 1: Information on sequencing reads obtained for each nucleosome mapping replicate. The strain 
column indicates the strains used. GA-6879 is the wild type and GA-8386 the shutdown strain grown in galactose:raffinose 
medium. A-C in the strain column indicates the four independent experiments with or without Zeocin treatment for 1h prior 
to MNase digestion. Column A shows the S. Cerevisiae reads and column B the reads from the C. glabrata spike-in control. 
 A B C=(A+B) E=(A/C) F=(B/C)*100 
Strain S. ce. C. glab. total Read fraction  S. cer. 
Read fraction 
C. glab. 
GA-6879_A 50692473.00 9866228.00 60558701.00 0.84 0.16 
GA-6879_A_Zeocin 46090144.00 13483686.00 59573830.00 0.77 0.23 
GA-6879_B 38787017.00 7282715.00 46069732.00 0.84 0.16 
GA-6879_B_Zeocin 36619974.00 10714730.00 47334704.00 0.77 0.23 
GA-6879_C 34427922.00 6626795.00 41054717.00 0.84 0.16 
GA-6879_C_Zeocin 29746798.00 7722737.00 37469535.00 0.79 0.21 
GA-6879_D 25931187.00 4679458.00 30610645.00 0.85 0.15 
GA-6879_D_Zeocin 43185379.00 12185328.00 55370707.00 0.78 0.22 
GA-8386_A 82089867.00 21788485.00 103878352.00 0.79 0.21 
GA-8386_A_Zeocin 53677477.00 20342128.00 74019605.00 0.73 0.27 
GA-8386_B 41546073.00 9859227.00 51405300.00 0.81 0.19 
GA-8386_B_Zeocin 32786223.00 12332953.00 45119176.00 0.73 0.27 
GA-8386_C 25328106.00 6741373.00 32069479.00 0.79 0.21 
GA-8386_C_Zeocin 27560758.00 10640545.00 38201303.00 0.72 0.28 
GA-8386_D 30336089.00 7284044.00 37620133.00 0.81 0.19 
GA-8386_D_Zeocin 31958581.00 12219914.00 44178495.00 0.72 0.28 
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Yeast strains used in this study 
Supplementary Table 2: Yeast strains used in this study. All strains are haploid and all except the SILAC strain and the 
Htz1-mEos imaging control are derived from the W303 background. 
Strain 
number 
Genotype Source 
BY MATa; his3del200; leu2del0; met15del0; trp1del63; ura3del0; (BY4733) 
exemplary 
genotype 
W303 MATa; ade2-1; trp1-1; his3-11; his3-15; ura3-1; leu2-3; leu2-112; (W303) 
exemplary 
genotype 
JKM179 MATα; hml::ADE1; hmr::ADE1; ade3::GALHO; leu2-3; lys5 trp1::hisG; ura3-52 (JKM179) 
exemplary 
genotype 
yAG-06A YHR018c::kanMX4; YIR034c::kanMX4 (BY4733) 1 
GA-6879 
MATa, RAD52-YFP; NUP49-GFP; ADE2::TetR-mCherry; lys5::LacI-CFP::TRP; leu2::LoxP; 
ZWF1:cutsite(Lmn::lys5::IsceIcs::LEU2::LacO array::Lmn); met10::lmn 
adaptamers::HIS3::TetOps-LexA (W303) 2 
GA-9773 MATa; PES4::4xLexA-lacO::TRP1; his3-15::GFP-LacI-HIS3; NUP49-GFP This study 
GA-9774 nhp6a::kanMX4; nhp6b::kanMX4, same as GA-9773 This study 
GA-9771 nhp6a::kanMX4; nhp6b::kanMX4, same as GA-6879 This study 
GA-9815 arp8::NAT, same as GA9771  
GA-9772 Isogenic to GA-6879 This study 
GA-7553 sml1::HIS3; same as GA-6879 This study 
GA-8132 arp8::NAT; same as GA-6879 This study 
GA-8182 ies4::NAT; same as GA-6879 This study 
GA-8185 swr1::NAT; same as GA-6879 This study 
GA-8202 arp5::NAT; same as GA-6879 This study 
GA-7551 rad51::NAT; in GA-6879 This study 
GA-7552 rad53::NAT; same as GA-7553 This study 
GA-7556 mec1::NAT; same as GA-7553 This study 
GA-8385 
MATa; Nup49-GFP; GFP-LacI::HIS3; hht2-hhf2∆ hht1-hhf1∆(no marker) + [#3495 pDM18 
pRS415; HHT2-HHF2; CEN/ARS, TRP1] (W303) This study 
GA-8386 
MATa; Nup49-GFP; GFP-LacI::HIS3; hht2-hhf2∆ hht1-hhf1∆(no marker) + [#3484 pRM102 
pUK420; GAL10-HHT2 GAL1-HHF2; CEN/ARS, URA3] (W303) This study 
GA-8387 
MATa; Nup49-GFP; GFP-LacI::HIS3; hht2-hhf2∆ hht1-hhf1∆(no marker) + [#3494 pDM9 
pRS416; HHT1-HHF1; CEN/ARS; URA3] (W303) This study 
GA-9775 LacO::LEU2::MGS1, same as GA8385 This study 
GA-9776 LacO::LEU2::MGS1, same as GA8386 This study 
GA-3364 MATa; HTB2-CFP::kanXM (W303) Brian Luke 
GA-9700 rad51::URA3; same as GA-3364 This study 
GA-9698 sml1::URA3; same as GA-3364 This study 
GA-9695 arp8::natMX; same as GA-3364 This study 
GA-9712 Rad53::natMX; same as GA-9712 This study 
GA-9594 MATα; Htz1-Eos::URA3; same as JKM179 This study 
GA-5816 MATα; Rad52-YFP; NUP49-GFP; HIS3::LacI-GFP (W303) This study 
YMB08 
(GA-9227) 
MATα; ura3-1::LacI-GFP-URA3; 515kb-XIV::lacO-TRP1; YGL117::tetR-mRFP-NATMX; 
196kb-XIV::tetO-LEU2 (W303) 
Kerstin 
Bystricky 
GA-9777 
MATα; YGL117(ARS714)::TetR-mRFP-NAT; ade2-1::His3p-CFP-lacI-URA3p-LambdacI-YFP-
ADE2; leu2-3,112 :: tetO-LEU2; 74kb :: LambdaO-HIS3; 40kb :: LacO-TRP1; RAD52-EGFP-
CaURA3 This study 
GA-1365 MATa, pre1-1, pre2-2 3 
GA-1366 Mata, WT strain isogenic to GA-1365 and GA-1366 3 
GA-1364 Mata, erg6::LEU2 4 
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Plasmids used in this study 
Supplementary Table 3: Plasmids used in this study 
Plasmid
number 
Description Type Yeast 
selection 
Bacterial 
selection 
Source 
#3484 pUK420-GAL10-HHT2 GAL1-HHF2 CEN/ARS URA3 AMP Addgene 5 
#3494 pRS416-HHT1-HHF1 CEN/ARS URA3 AMP 6 
#3495 pRS414-HHT2-HHF2 CEN/ARS TRP1 AMP 7 
#279 pRS406 integrating URA3 AMP Addgene 
#1049 pAG32 see source see source see source 8 
#1050 pAG60 see source see source see source 8 
#2422 pWJ132-hphMX4-Gal1-10 2µ plasmid ADE2/hphMX4 AMP This study 
 
 
 
Antibodies used in this study 
Supplementary Table 4: Antibodies used in this study 
Antibody Supplier Conditions used 
Mouse α Rad53 Custom made antibody (GenScript) 1:200 in milk 
Rabbit α H4 Abcam AB 10158 1:5000 or 1:7500 in BSA 
Mouse α actin MAB1501 1:10,000 in milk 
Goat α MCM2 Santa Cruz (SC 6680) 1:3000 in BSA 
Rabbit α γH2A Custom made antibody 1:3000 i BSA 
Rabbit α H3 Abcam AB1791 1:10,000 in BSA 
Rabbit α Ubiquitin Abcam (AB19247) 1:2000 in milk 
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Supplementary Notes 
Estimating the anomalous diffusion exponent α and the diffusion coefficient 
We computed the cross-correlation (CC) function using 1:  
 ,))(()((1=)( 2
1=
ttktk
tN
tC cc
tpN
kp
Δ+−Δ
− ∑
−
RR  (6) 
 for 11,= −Tt , where pN  is the number of points in the trajectory. In many studies the CC is 
referred to as the MSD function 2,3 although these two functions are distinct1. The MSD is defined as 
the squared displacement with respect to the initial trajectory position, averaged over time: 
              ( )2MSD(t)= ( ) (0)c cR t R− . 
For short times, )(tC  increases as a power law  
 .=)( αCttC  (7) 
where 0>C . To extract the coefficient α, we computed )(tC  from empirical trajectories and fitted 
the first seven points of the curve to a power law. A chromatin or DNA locus is characterized 
experimentally by 1<α 4,5, while for normal diffusion 1=α . In the Rouse polymer model6, the 
anomalous exponent is 0.5=α  computed for intermediate time regime (see 6). 
To compute the diffusion coefficient of the tagged monomer, we use the following empirical 
estimator described in 1:  
 ,))1)(()((
4
1= 2
1
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t
D cc
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k
c Δ+−ΔΔ ∑
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RR  (8) 
 For short time interval Dbt /2=Δ , the locus motion is Brownian and the diffusion coefficient is well 
approximated by eq.(8). 
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Estimating the effective spring coefficient ck  
Because the chromatin interacts locally with its environment, we estimated this interaction using a 
polymer model7, by a harmonic well of strength k  acting on a single monomer nR . The potential 
energy of the interaction is  
 ,)(
2
1=)( 2µRR −nn kU  (9) 
 where µ  is the fix position of the interaction. The velocity of an observed monomer c , averaged over 
many trajectories is driven by this interacting force, following the relation described in 7:  
 ( )
0
( ) ( ){ | ( ) = }= ,lim c c c cn
t
t t tE t Dk
tΔ →
+Δ −
− −
Δ
R R R x x µ  (10) 
 where )(tcR  is the position of locus c  at time t and D  the diffusion coefficient and {. | ( ) = }cE tR x
means averaging over trajectory realizations such that the condition ( ) =c tR x is satisfied. Relation 
(18) links the average velocity of the observed monomer c  to the force applied at a distance || nc − . 
For a Rouse polymer, with a potential well of type (17), the effective spring coefficient is given by  
 ,
||
=
knc
kkcn −+κ
κ  (11) 
 where κ  is the monomer-monomer spring coefficient. We estimated ck  from the empirical locus 
trajectories )(tcR  by  
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 where i  is the spatial direction (in two dimensions, we sum over the x and y components) and pN  is 
the number of points in the trajectory. In practice, the quantity 〉〈 icR  is computed by averaging over the 
trajectory. The diffusion coefficient cD  can be computed by using eq. 8.  
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